Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution	Test outcome NA N A AA L LL H HH
3024172	s-epo	U/l (u/l)	4069	5150	0.00%
3024172	s-epo	IU/l (u/l)	1860	2352	0.38%
3024172	s-epo	— (—)	1100	1210	100.00%	Distribution not available
3024172	s-erytropoietiini	U/l (u/l)	184	187	0.00%
3024172	s-epo	U/l_______ (u/l)	183	227	0.00%
3024172	erytropoietiini	IU/l (u/l)	107	114	0.00%
3024172	s-erytropoietiini	IU/l (u/l)	97	101	0.00%
3024172	s-erytropoietiini	U/l_______ (u/l)	73	82	0.00%
3024172	erytropoietiini,seerumista	IU/l (u/l)	52	54	0.00%
3024172	s-erytropoietiini	IU/l______ (u/l)	19	20	0.00%
3024172	s-erytropoietiini	— (—)	12	12	100.00%	Distribution not available
3024172	erytropoietiini,seerumista	IU/L (u/l)	5	5	0.00%	Distribution not available	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Other and unspecified diseases of blood and blood-forming organs

255

152

21.96

318.44

1.5

1.2

52.48

37.46

u/l

0.40

225

135

Primary_lymphoid and hematopoietic malignant neoplasms

837

1880

4.72

307.65

1.3

95.25

27.89

u/l

12.49

771

1601

Renal failure

1383

3343

3.66

307.65

1.3

32.84

36.88

u/l

0.55

1234

2851

Liquid cancers

1957

1851

11.35

307.65

1.3

1.2

62.18

20.49

u/l

17.81

1711

1581

Polycythaemia vera

552

197

47.02

307.65

1.3

1.2

17.10

20.45

u/l

0.26

416

170

Chronic kidney disease

1039

2442

4.30

307.65

1.2

1.3

29.65

39.10

u/l

1.63

939

2080

Aplastic and other anaemias

1517

3212

4.53

307.65

1.3

78.71

22.14

u/l

18.60

1381

2703

Acute myeloid leukaemia and myelodysplastic syndromes

270

137

26.94

307.65

1.4

1.1

148.92

21.40

u/l

11.12

243

120

Other diseases of blood and blood-forming organs, wide

1353

1500

10.21

307.65

1.4

1.2

45.38

30.92

u/l

1.80

1215

1287

All chronic kidney diseases

1406

3399

3.40

307.65

1.3

31.25

34.87

u/l

0.49

1261

2906

Other and unspecified anaemias

1425

3050

4.60

307.65

1.3

77.47

22.50

u/l

17.55

1296

2561

Anaemias

478

279

11.33

307.65

1.4

1.2

89.28

13.80

u/l

6.97

441

253

Myelodysplastic syndrome, including Hilmo

439

170

39.55

307.65

1.4

1.1

120.32

19.52

u/l

16.05

401

143

Myeloproliferative diseases (CML excluded)

1008

500

29.37

307.65

1.3

1.2

24.14

40.71

u/l

1.36

836

435

Myelodysplastic syndrome

221

60.62

307.65

1.4

1.1

146.93

19.94

u/l

8.97

198

Other diseases of blood and blood-forming organs

975

444

32.57

307.65

1.4

1.2

26.08

38.52

u/l

0.92

874

381

Secondary polycythaemia

505

139

76.43

307.65

1.4

1.3

14.69

45.38

u/l

1.31

450

120

Myeloproliferative diseases

1052

555

26.83

307.65

1.3

1.2

27.47

39.15

u/l

0.86

876

486

L01XX Other antineoplastic agents

700

395

24.97

307.65

1.3

32.78

43.07

u/l

0.49

578

338

Other anaemias

1430

3070

4.57

307.65

1.3

79.35

22.41

u/l

17.16

1301

2578

Liquid cancers, including Hilmo

2131

2107

9.92

307.65

1.4

1.2

62.47

18.23

u/l

23.01

1874

1793

Essential (haemorrhagic) thrombocythaemia

439

208

29.40

307.65

1.4

1.2

27.04

16.82

u/l

0.90

398

178

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

2990

3933

5.33

307.65

1.3

50.49

17.93

u/l

19.94

2692

3353

Heart failure, not strict

1596

3771

2.92

297.14

1.3

36.81

30.88

u/l

0.94

1419

3248

Multiple myeloma, including Hilmo

294

273

12.64

280.80

1.4

1.1

84.29

20.70

u/l

8.30

281

235

Type 2 diabetes

1792

4009

2.63

266.52

1.2

1.3

27.94

34.02

u/l

1.05

1574

3502

Renal tubulo-interstitial diseases

1699

4846

2.62

266.49

1.3

34.76

33.49

u/l

0.14

1504

4198

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

1742

3996

2.63

260.83

1.2

1.3

29.02

33.43

u/l

0.65

1518

3487

Diabetes mellitus

1793

4101

2.57

253.77

1.2

1.3

27.96

33.82

u/l

1.00

1577

3586

Diabetes, varying definitions

1785

4104

2.56

252.33

1.2

1.3

28.01

33.81

u/l

0.98

1571

3587

Type 2 diabetes, wide definition

1545

3659

2.72

249.62

1.2

1.4

32.92

34.46

u/l

0.15

1357

3188

Heart failure and antihypertensive medication

573

690

5.59

247.30

1.2

1.4

39.32

43.87

u/l

0.25

517

597

Chronic myeloproliferative disease

177

31.62

247.05

1.5

1.2

68.87

43.46

u/l

0.62

161

Multiple myeloma and malignant plasma cell neoplasms

297

346

9.99

240.54

1.3

82.79

35.10

u/l

3.89

285

296

Type 2 diabetes, strict (exclude DM1)

1699

3942

2.55

237.97

1.2

1.3

27.93

34.16

u/l

0.98

1491

3443

Type 2 diabetes, definitions combined

1689

3923

2.55

236.03

1.2

1.3

27.99

34.06

u/l

0.93

1483

3424

Diabetes, insulin treatment (Kela reimbursement)

1859

4643

2.42

235.70

1.2

1.3

29.79

33.36

u/l

0.49

1618

4056

Heart failure,strict

1189

2849

3.00

233.96

1.2

1.4

37.86

34.58

u/l

0.37

1054

2422

All kidney diseases

1753

4911

2.43

231.16

1.3

34.66

33.29

u/l

0.15

1551

4264

Type 2 diabetes, definitions combined, including avohilmo

1668

3869

2.53

230.30

1.2

1.3

26.24

34.31

u/l

1.70

1467

3384

Other abnormal findings of blood chemistry

276

321

9.81

222.99

1.4

1.3

22.03

38.16

u/l

1.17

258

276

Multiple myeloma, Monoclonal gammopathy of undetermined significance (MGUS)

200

155

15.48

214.70

1.4

1.1

75.63

21.55

u/l

9.40

190

134

Multiple myeloma

200

155

15.48

214.70

1.4

1.1

75.63

21.55

u/l

9.40

190

134

Diabetes medication

1787

4509

2.35

211.40

1.2

1.3

29.91

33.42

u/l

0.48

1569

3939

Other (not insulin) diabetes medications

1706

4358

2.33

198.91

1.2

1.3

27.80

33.55

u/l

1.01

1491

3804

Heart failure, strict

1283

3482

2.63

198.47

1.2

1.3

37.88

35.16

u/l

0.32

1137

2985

All-cause Heart Failure

1255

3443

2.60

190.35

1.2

1.3

37.25

34.98

u/l

0.26

1114

2950

Hypertensive diseases (excluding secondary)

814

1410

3.42

188.55

1.3

31.77

23.06

u/l

0.82

715

1229

Biguanides

1667

4487

2.28

185.48

1.2

1.3

26.77

33.83

u/l

1.57

1453

3913

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

697

2160

3.33

179.95

1.2

1.3

24.40

31.07

u/l

0.74

605

1884

Glucagon-like peptide-1 (GLP-1) analogues

697

2160

3.33

179.95

1.2

1.3

24.40

31.07

u/l

0.74

605

1884

Dipeptidyl peptidase 4 (DPP-4) inhibitors

1131

3562

2.55

170.23

1.2

1.4

35.69

36.07

u/l

0.03

987

3099

Hypertension

1224

2769

2.53

167.88

1.3

30.17

31.79

u/l

0.14

1083

2406

Hypertensive diseases

1224

2770

2.53

167.82

1.3

30.17

31.79

u/l

0.14

1083

2407

Hypertension, essential

1208

2730

2.54

166.96

1.3

31.40

32.05

u/l

0.05

1076

2375

Metabolic disorders

1593

4409

2.20

163.12

1.3

30.87

31.76

u/l

0.10

1407

3823

Endocrine, nutritional and metabolic diseases

1120

2171

2.64

161.26

1.3

29.11

34.04

u/l

0.48

996

1891

Malignant neoplasm, including Hilmo

1370

3487

2.32

158.02

1.4

1.2

50.90

16.51

u/l

10.22

1207

3027

Other bacterial diseases

1604

5093

2.11

152.96

1.3

51.48

24.61

u/l

8.58

1410

4425

Insulin medication

1090

3798

2.42

150.59

1.2

1.3

36.63

34.53

u/l

0.18

954

3296

Other bacterial diseases, including avohilmo

1647

4986

2.09

150.12

1.3

47.19

24.96

u/l

6.44

1453

4329

Malignant neoplasm

1343

3508

2.27

148.17

1.4

1.2

50.48

17.82

u/l

9.07

1175

3052

Other heart diseases

679

1418

3.16

145.35

1.2

1.3

34.87

22.79

u/l

1.54

600

1237

Fever of other and unknown origin

1018

3686

2.43

143.37

1.5

1.3

60.73

27.51

u/l

6.62

909

3182

Cardiovascular diseases (excluding rheumatic etc)

801

1629

2.85

138.47

1.3

32.61

24.98

u/l

0.69

697

1432

Any reimbursement code in KELA

697

1116

3.17

137.17

1.3

1.2

34.21

15.11

u/l

3.07

606

971

Antihypertensive medication - note that there are other indications

723

1248

3.06

137.03

1.3

28.89

37.02

u/l

0.62

634

1105

Malignant neoplasm, wide definition

1337

3584

2.20

136.49

1.4

1.2

50.20

18.10

u/l

8.79

1175

3119

Malignant neoplasm

1318

3543

2.21

135.93

1.4

1.2

51.24

18.06

u/l

9.01

1152

3083

Monoclonal gammopathy of undetermined significance (MGUS), including Hilmo

200

287

7.65

134.50

1.4

1.2

45.31

19.37

u/l

5.11

194

243

Bacterial infection, other or unspecified

1024

3801

2.32

128.02

1.3

62.80

25.93

u/l

10.08

903

3268

Bacterial infection, other or unspecified, including avohilmo

1083

3989

2.26

127.76

1.3

61.51

25.88

u/l

10.18

958

3432

Atrial fibrillation and flutter with reimbursement

467

817

3.69

123.82

1.2

1.4

23.84

26.41

u/l

0.28

412

701

Dyspnoea

1479

5445

1.98

121.65

1.3

38.84

31.33

u/l

1.21

1317

4720

Abnormal findings on examination of blood, without diagnosis

966

3869

2.31

121.19

1.4

1.3

36.72

31.71

u/l

0.54

875

3343

Bacterial Sepsis

944

3395

2.34

120.81

1.3

53.44

29.92

u/l

4.46

825

2928

Acute renal failure

517

1708

3.13

120.26

1.3

37.37

36.62

u/l

0.04

444

1458

Other disorders of white blood cells

197

315

6.77

119.33

1.4

1.2

47.98

46.01

u/l

0.04

182

268

Implicit Sepsis

1290

4658

2.07

119.18

1.3

44.00

27.91

u/l

2.84

1118

4053

Diseases of arteries, arterioles and capillaries (FINNGEN)

432

827

3.69

118.27

1.2

1.4

27.57

27.98

u/l

0.02

375

705

Hypothyroidism, levothyroxine purchases

285

288

5.62

117.33

1.4

1.2

20.93

13.56

u/l

0.76

256

262

Hypothyroidism and >3 levothyroxin purchases

285

288

5.62

117.33

1.4

1.2

20.93

13.56

u/l

0.76

256

262

Hypothyroidism (congenital or acquired)

286

293

5.54

116.06

1.4

1.2

22.54

13.55

u/l

0.97

257

267

Gout

654

2106

2.74

116.03

1.3

44.90

34.38

u/l

1.03

595

1809

Influenza and pneumonia

1596

5184

1.92

115.46

1.3

52.72

24.22

u/l

8.28

1418

4514

Heart failure and coronary heart disease

883

2629

2.41

114.89

1.2

1.3

31.29

37.55

u/l

1.09

783

2236

Pneumonias (Asthma/COPD co-morbidities)

1543

5286

1.93

114.33

1.3

54.49

24.55

u/l

8.36

1372

4607

Disorders of lipoprotein metabolism and other lipidaemias

1361

4141

2.02

113.69

1.2

1.3

29.27

32.00

u/l

0.37

1204

3594

All pneumoniae

1549

5301

1.92

113.21

1.3

54.34

24.71

u/l

8.24

1376

4620

Medical observation and evaluation for suspected diseases and conditions

1005

2257

2.30

110.43

1.3

36.79

27.85

u/l

1.18

867

1936

Implicit bacterial Sepsis, including avohilmo

899

3318

2.30

110.08

1.3

50.87

30.58

u/l

3.28

775

2866

ILD medications

1684

4890

1.87

109.93

1.3

44.44

24.55

u/l

6.35

1502

4228

Atrial fibrillation and flutter

495

1005

3.24

109.74

1.2

1.4

26.62

26.36

u/l

0.02

436

869

Cardiovascular diseases

698

1370

2.73

109.74

1.3

30.35

27.54

u/l

0.17

602

1210

Nutritional anaemias

905

3887

2.26

109.65

1.3

53.00

32.82

u/l

2.55

787

3336

Implicit Sepsis, including avohilmo

1334

4864

1.98

109.39

1.3

41.62

27.84

u/l

2.35

1158

4240

Implicit bacterial Sepsis

838

3113

2.36

109.25

1.3

53.35

31.32

u/l

3.37

723

2686

Iron deficiency anaemia

803

3395

2.37

108.76

1.3

46.89

32.36

u/l

1.54

694

2915

Non-invasive ventilation

399

1008

3.48

108.12

1.2

1.4

50.18

28.04

u/l

1.49

362

870

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

1365

4058

1.99

107.81

1.3

54.83

26.05

u/l

6.47

1212

3523

1365

4058

1.99

107.81

1.3

54.83

26.05

u/l

6.47

1212

3523

Other heart diseases, wide

1281

3866

2.03

107.64

1.3

29.62

29.32

u/l

0.03

1137

3368

Cardiac arrhythmias

753

1934

2.52

107.55

1.3

23.06

27.99

u/l

0.96

668

1684

Transplanted organ and tissue status

284

683

4.38

107.53

1.3

78.38

29.26

u/l

3.22

258

591

ILD medications: prednisolone, methylprednisolone, prednisone

1620

4856

1.87

106.32

1.3

43.93

24.02

u/l

6.09

1439

4194

Insulin, intermediate and long-acting

1010

4657

2.13

105.71

1.2

1.3

33.84

32.42

u/l

0.12

877

4043

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

1505

5360

1.89

105.68

1.3

53.48

25.30

u/l

7.36

1339

4667

Depression medications

306

321

4.85

103.51

1.4

1.2

27.48

13.20

u/l

1.01

262

294

Explicit Sepsis, including avohilmo

834

3367

2.29

102.96

1.4

1.3

61.38

29.89

u/l

5.00

737

2906

Sleep apnoea

1494

5061

1.88

102.34

1.3

27.48

33.24

u/l

1.21

1294

4442

Other and unspecified disorders of white blood cells

155

227

7.45

102.29

1.4

1.2

53.61

43.89

u/l

0.21

143

197

Insulin, combination of fast acting with intermediate-acting or long-acting

1092

4910

2.05

102.23

1.2

1.3

36.64

32.52

u/l

0.43

955

4262

Pneumonia, organism unspecified

1395

5065

1.91

101.73

1.3

52.07

24.50

u/l

7.94

1233

4405

Septicaemia

798

3203

2.31

101.45

1.4

1.3

61.50

27.21

u/l

5.57

706

2745

Abnormalities of breathing

1293

3765

1.98

101.28

1.3

33.71

31.28

u/l

0.24

1153

3261

Non-ischemic cardiomyopathy

626

1939

2.62

100.57

1.3

42.55

38.60

u/l

0.27

561

1647

Explicit Sepsis

815

3310

2.28

100.43

1.4

1.3

62.43

30.22

u/l

4.98

718

2855

Unspecified kidney failure

287

740

4.06

98.73

1.4

1.3

26.66

36.39

u/l

1.15

260

628

Heart failure and bmi 25plus

742

2088

2.43

97.22

1.2

1.4

39.27

34.25

u/l

0.47

649

1775

Any gastric operation

1029

2416

2.16

96.82

1.3

1.2

39.13

20.08

u/l

3.49

895

2109

GASTRO-related operations

1029

2416

2.16

96.82

1.3

1.2

39.13

20.08

u/l

3.49

895

2109

Gout, FINNGEN

654

2704

2.47

96.74

1.3

44.90

35.10

u/l

0.93

595

2316

Infections, IBD-co-morbidities

271

434

4.49

96.53

1.3

63.58

37.76

u/l

1.15

245

375

Continuous positive airway pressure

333

773

3.68

96.43

1.3

1.4

43.58

29.38

u/l

0.75

269

662

Coagulation defects, purpura and other haemorrhagic conditions

424

1427

3.06

95.53

1.5

1.3

85.31

30.72

u/l

4.46

390

1239

Pure hypercholesterolaemia

1220

3987

1.97

95.34

1.2

1.3

31.47

32.71

u/l

0.13

1087

3458

Condition for Implicit Sepsis (Organ dysfunction codes)

1318

4869

1.90

94.38

1.3

38.31

27.76

u/l

2.02

1142

4244

Haemolytic anaemias

146

220

7.29

94.04

1.7

1.2

58.02

35.29

u/l

0.93

134

191

Statin medication

888

2260

2.24

94.03

1.2

1.3

34.66

35.97

u/l

0.08

777

1958

Hypertensive heart and/or renal disease

498

1298

2.87

93.00

1.2

1.4

28.80

40.66

u/l

1.90

430

1097

Thrombocytopenia, unspecified

228

520

4.66

92.77

1.5

1.2

109.66

34.04

u/l

5.20

214

449

Other septicaemia, including avohilmo

726

3006

2.31

92.49

1.4

1.3

62.97

27.68

u/l

4.99

639

2573

Condition for Implicit Sepsis (Organ dysfunction codes), including avohilmo

1332

4847

1.87

91.66

1.3

37.09

27.54

u/l

1.84

1162

4225

Sleep apnoea, including avohilmo

1498

5049

1.81

90.52

1.3

27.81

33.64

u/l

1.12

1296

4437

Purpura and other haemorrhagic conditions

333

1006

3.44

90.29

1.4

1.3

102.24

30.77

u/l

4.80

308

871

Other and unspecified iron deficiency

631

2657

2.42

90.26

1.3

43.79

32.31

u/l

0.91

545

2283

Examination and observation for other reasons

870

2244

2.21

89.90

1.3

38.49

27.79

u/l

1.63

799

1924

Dialysis, with operation codes

312

908

3.58

89.83

1.3

38.51

35.56

u/l

0.16

282

782

Other septicaemia

708

2952

2.30

89.80

1.4

1.3

64.14

27.93

u/l

4.98

621

2526

Neoplasms

974

2438

2.12

88.59

1.4

1.2

46.81

16.04

u/l

5.47

867

2129

First line medication for Crohn's disease

1576

4795

1.78

88.19

1.4

1.2

43.76

24.63

u/l

5.04

1403

4144

Other nutritional deficiencies

1020

4755

1.98

87.92

1.2

1.3

31.92

32.24

u/l

0.02

869

4168

Obesity

965

4563

2.02

87.60

1.2

1.3

31.59

31.67

u/l

0.01

823

3999

Obesity and other hyperalimentation

968

4588

2.01

86.91

1.2

1.3

31.56

31.73

u/l

0.01

824

4022

Other and unspecified aplastic anaemias

15.55

86.87

1.4

1.3

355.07

22.97

u/l

5.02

L04AD Calcineurin inhibitors

269

728

3.86

86.39

1.3

129.71

26.60

u/l

4.92

249

628

Obesity due to excess calories

736

3375

2.21

86.23

1.2

1.3

34.17

29.49

u/l

0.31

622

2956

Chronic lymphocytic leukaemia

123

172

7.87

84.83

1.4

1.2

88.14

19.26

u/l

1.57

113

146

Chronic lymphocytic leukaemia and small lyphocytis leukaemia, including Hilmo

123

172

7.87

84.83

1.4

1.2

88.14

19.26

u/l

1.57

113

146

Chronic lymphocytic leukaemia, helper endpoint

123

172

7.87

84.83

1.4

1.2

88.14

19.26

u/l

1.57

113

146

Erysipelas, including avohilmo

1152

4542

1.90

84.39

1.2

1.3

35.99

25.23

u/l

2.86

1011

3941

ILD medications: immunosuppressive drugs

965

4453

1.99

83.50

1.3

64.97

23.64

u/l

7.91

882

3860

Myeloid leukaemia

129

195

7.40

83.24

1.3

1.2

148.14

30.95

u/l

4.19

117

171

Other soft tissue disorders, not elsewhere classified

1352

4264

1.82

81.95

1.3

29.82

33.84

u/l

0.60

1186

3706

Other special examinations and investigations of persons without complaint or reported diagnosis

924

2257

2.10

81.20

1.3

33.78

27.85

u/l

0.63

810

1936

Lymphoid leukaemia

185

400

4.95

80.71

1.4

1.3

96.55

42.80

u/l

1.52

171

352

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

531

1301

2.60

80.44

1.3

38.51

24.13

u/l

1.15

481

1133

Pain in limb

1214

4199

1.86

80.14

1.3

30.66

34.19

u/l

0.45

1073

3648

Bleeding

1301

5123

1.80

79.39

1.3

42.08

30.28

u/l

1.78

1146

4444

Familial erythrocytosis

28.48

78.91

1.3

1.1

12.99

20.02

u/l

0.83

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

1385

4990

1.77

78.34

1.2

1.3

40.14

29.40

u/l

1.95

1205

4367

Oral corticosteroids

1533

5269

1.72

77.42

1.3

41.08

27.68

u/l

2.80

1374

4558

Dental caries

473

1761

2.59

77.38

1.5

1.3

69.05

27.94

u/l

4.10

419

1537

Glomerular diseases

395

1440

2.83

77.11

1.2

1.3

26.27

35.24

u/l

1.16

362

1238

Polyarthropathies

1021

3426

1.94

76.68

1.3

41.84

31.15

u/l

1.27

920

2980

Tramadol

1129

3660

1.87

75.85

1.2

41.11

27.27

u/l

1.68

1004

3174

Valvular heart disease excluding rheumatic fever

737

2481

2.15

75.28

1.3

36.49

31.97

u/l

0.49

651

2125

Non-rheumatic valve diseases

735

2473

2.15

75.03

1.3

36.53

31.95

u/l

0.50

649

2117

Caries of dentine

429

1590

2.66

74.47

1.5

1.3

75.13

26.46

u/l

4.68

380

1393

Malaise and fatigue

820

3205

2.04

74.46

1.4

1.3

36.91

27.15

u/l

1.65

715

2753

General symptoms and signs

1444

4183

1.74

73.73

1.3

38.49

26.03

u/l

2.47

1274

3624

Parasetamol

968

2494

1.98

73.33

1.3

1.2

34.51

28.54

u/l

0.59

853

2181

Disorders of other endocrine glands

690

3245

2.12

72.62

1.2

1.3

28.25

31.87

u/l

0.30

617

2808

Cerebrovascular diseases (FINNGEN)

412

1058

2.77

72.27

1.2

1.4

29.45

26.45

u/l

0.20

369

913

Codeine

1246

3791

1.79

71.04

1.3

1.2

32.77

27.05

u/l

0.72

1101

3298

Inflammatory bowel disease treatment related agents

1589

5344

1.66

69.98

1.4

1.3

44.76

28.02

u/l

3.62

1421

4628

Acquired haemolytic anaemia

104

153

7.52

68.67

1.4

1.2

59.50

36.42

u/l

1.14

134

Diseases of arteries, arterioles and capillaries

1094

4486

1.81

68.63

1.2

1.3

34.40

34.47

u/l

0.01

959

3886

Nephropathy related operations

293

974

3.13

68.01

1.2

1.3

38.06

40.29

u/l

0.11

265

847

Percutaneous Coronary Intervention

1168

4018

1.79

67.65

1.2

1.3

27.94

34.10

u/l

1.10

1032

3483

Emergency coronary revascularization (for ACS)

1273

4455

1.74

67.64

1.2

1.3

28.41

33.90

u/l

1.02

1119

3854

Hypothyroidism, drug reimbursement

145

179

5.74

67.64

1.2

16.59

8.42

u/l

2.69

130

160

Pain in throat and chest

1126

3728

1.80

67.08

1.2

1.3

28.45

31.24

u/l

0.37

985

3227

Persons encountering health services for specific procedures and health care

1454

5198

1.66

65.20

1.4

1.2

46.59

26.20

u/l

4.26

1291

4518

Complications of surgical and medical care, not elsewhere classified

1419

5742

1.66

65.01

1.3

42.13

29.81

u/l

1.91

1255

4996

Coronary revascularization (ANGIO or CABG)

1159

4021

1.77

64.96

1.2

1.3

28.05

34.08

u/l

1.06

1026

3486

Opioids

1275

3828

1.73

64.47

1.3

1.2

39.03

26.89

u/l

1.79

1116

3332

Glomerular disorders in diseases classified elsewhere

277

923

3.12

64.03

1.2

1.3

25.53

40.39

u/l

1.47

251

799

Haemorrhage from respiratory passages

598

2501

2.15

63.74

1.3

41.95

32.88

u/l

0.65

532

2134

Hypertensive Heart Disease

413

1247

2.56

63.24

1.2

1.4

30.50

41.51

u/l

1.41

351

1060

Any event in cancer register

1189

4021

1.74

62.81

1.4

1.2

53.69

18.70

u/l

8.49

1046

3505

Oedema, not elsewhere classified

549

2483

2.19

62.77

1.3

39.81

28.68

u/l

1.11

486

2114

Erysipelas

890

4188

1.85

62.25

1.2

1.3

38.77

25.20

u/l

3.21

781

3618

Asthma, unspecified (mode), excluding more controls

683

2408

2.05

62.06

1.3

35.87

25.58

u/l

1.02

617

2079

Diseases of oesophagus, stomach and duodenum

1463

5322

1.64

61.47

1.3

35.53

30.13

u/l

0.89

1278

4649

Codeine or tramadol medication

1541

5206

1.62

61.22

1.3

31.76

33.06

u/l

0.13

1357

4531

Sleep disorders (combined)

1501

4844

1.63

60.72

1.2

1.3

28.70

35.40

u/l

1.29

1292

4253

Anaemia in chronic diseases classified elsewhere

142

7.15

59.19

1.3

1.2

61.26

34.82

u/l

0.52

123

Acute myeloid leukaemia

10.72

58.14

1.3

1.2

191.66

16.89

u/l

4.43

Acute myeloid leukaemia, including Hilmo

10.72

58.14

1.3

1.2

191.66

16.89

u/l

4.43

Acute myeloid leukaemia, helper endpoint

10.72

58.14

1.3

1.2

191.66

16.89

u/l

4.43

Ischemic heart diseases

1167

4102

1.71

57.97

1.2

1.3

28.30

33.65

u/l

0.90

1031

3560

Symptoms and signs involving the circulatory and respiratory systems

1260

3768

1.69

57.63

1.3

29.47

31.26

u/l

0.21

1118

3264

Acute tubulo-interstitial nephritis

848

3945

1.83

57.17

1.4

1.3

37.20

35.56

u/l

0.12

745

3391

Gout, idiopatic and unspecified

501

2343

2.19

56.59

1.3

35.51

34.94

u/l

0.04

459

2017

Major coronary heart disease event

1197

4291

1.68

56.38

1.2

1.3

28.46

33.80

u/l

0.93

1062

3713

Hard cardiovascular diseases

1146

4013

1.70

56.07

1.2

1.3

33.27

32.64

u/l

0.05

1015

3484

Neurological diseases, wide definition

323

566

2.89

55.60

1.3

1.2

28.75

33.91

u/l

0.24

280

502

Episodal and paroxysmal disorders

1403

4413

1.62

55.57

1.3

31.17

34.19

u/l

0.34

1231

3840

Gout, strict definition

390

1674

2.40

54.37

1.3

36.64

34.44

u/l

0.12

355

1432

Persons encountering health services for examination and investigation

836

2257

1.87

54.15

1.3

40.04

27.85

u/l

1.45

738

1936

Hypogonadotropic hypogonadism

110

217

5.46

53.65

1.2

1.3

42.06

34.56

u/l

0.09

191

Disorders of mineral metabolism

191

566

3.50

53.62

1.3

28.08

37.95

u/l

0.86

173

481

Hernia of abdominal wall, postoperative

300

1138

2.67

53.18

1.3

1.2

40.37

19.75

u/l

1.51

260

983

Asthma, excluding more controls

893

2541

1.82

53.07

1.2

1.3

28.91

25.32

u/l

0.41

810

2200

Covid-19 confirmed case

612

3145

1.97

52.90

1.4

1.3

55.63

31.96

u/l

2.69

560

2692

Insulin, fast-acting

577

2913

2.01

52.62

1.2

1.3

29.78

31.46

u/l

0.12

515

2530

Gout, unspecified

415

1858

2.29

52.34

1.4

1.3

35.41

36.31

u/l

0.05

382

1591

Disorders of gallbladder, biliary tract and pancreas

1369

5392

1.59

52.26

1.2

1.3

32.65

31.57

u/l

0.10

1194

4694

Combinations of oral blood glucose lowering drugs

476

2250

2.16

52.17

1.2

1.4

27.87

37.41

u/l

1.09

415

1955

Secondary hypertension

141

338

4.23

52.15

1.2

1.3

51.75

29.77

u/l

0.54

128

288

COPD/asthma/ILD related infections

1308

4058

1.63

51.98

1.3

40.94

26.05

u/l

3.37

1159

3523

COPD/asthma related infections

1308

4058

1.63

51.98

1.3

40.94

26.05

u/l

3.37

1159

3523

Other disorders of fluid, electrolyte and acid-base balance

510

2324

2.10

51.84

1.3

34.08

37.32

u/l

0.33

435

1990

Diseases of spleen

8.16

51.37

1.3

1.2

118.74

36.53

u/l

0.85

Implicit viral Sepsis, including avohilmo

495

2392

2.10

50.75

1.3

62.27

32.44

u/l

2.21

431

2050

Genitourinary diseases

778

2098

1.88

50.67

1.3

35.47

33.50

u/l

0.12

684

1839

Certain infectious and parasitic diseases

1224

3760

1.64

50.59

1.3

1.2

43.85

23.31

u/l

4.56

1068

3252

General examination and investigation of persons without complaint and reported diagnosis

798

2254

1.85

50.54

1.3

34.14

27.85

u/l

0.71

697

1934

Used for control exclusion in common control thyroid runs

1384

4424

1.59

50.10

1.3

35.25

29.42

u/l

0.73

1225

3828

Paroxysmal tachycardia

273

847

2.71

48.49

1.2

1.4

24.69

28.76

u/l

0.38

246

727

Asthma, unspecified (mode)

710

2791

1.85

48.37

1.3

35.39

25.76

u/l

0.99

638

2415

STROKE

732

2710

1.84

47.75

1.2

1.3

36.49

31.70

u/l

0.36

639

2351

Persons encountering health services in other circumstances, wide

1535

5190

1.53

47.51

1.3

39.88

29.80

u/l

1.66

1361

4508

Asthma (only as main-diagnosis), excluding more controls

818

2541

1.79

47.46

1.2

1.3

28.50

25.32

u/l

0.35

739

2200

Diverticular disease of intestine

1051

3980

1.66

47.32

1.3

39.83

30.84

u/l

0.93

934

3449

Conduction disorders

453

1718

2.14

47.29

1.3

1.4

26.59

31.68

u/l

0.79

384

1456

Complications of procedures, not elsewhere classified

1111

5593

1.61

46.99

1.4

1.3

36.62

30.12

u/l

0.78

987

4862

Coronary atherosclerosis

940

3519

1.70

46.63

1.2

1.3

32.37

35.63

u/l

0.35

827

3036

Other pulmonary diagnosis

995

2964

1.69

46.35

1.3

40.05

25.36

u/l

2.12

880

2568

Other diseases of intestines

1340

4817

1.56

46.00

1.3

32.83

30.44

u/l

0.28

1186

4199

Insulin, fast-acting or short human

578

3067

1.91

45.58

1.2

1.3

29.74

31.65

u/l

0.14

516

2659

Finngen Rheumatological endpoints

1213

4363

1.59

45.24

1.2

1.3

37.01

28.72

u/l

1.00

1067

3797

Complications of medical and surgical care

1020

5689

1.62

45.22

1.4

1.3

45.29

31.16

u/l

1.87

890

4951

Implicit viral Sepsis

362

1631

2.26

44.85

1.3

72.47

33.47

u/l

2.26

319

1403

Viral Sepsis

362

1632

2.26

44.78

1.3

72.47

33.47

u/l

2.26

319

1403

Excluding asthma or asthma-COPD overlap

987

2964

1.68

44.65

1.3

39.33

25.36

u/l

1.94

870

2568

Periodontitis

1356

5674

1.53

44.35

1.3

36.78

31.85

u/l

0.48

1173

4960

Cardiomyopathy

292

1207

2.47

44.10

1.2

1.4

30.43

30.95

u/l

0.03

268

1028

Gastrointestinal diseases

687

1861

1.86

44.06

1.3

36.51

22.17

u/l

1.69

602

1608

Chronic periodontitis, including avohilmo

1353

5681

1.53

43.81

1.3

36.73

31.86

u/l

0.47

1171

4967

Care involving dialysis

187

622

3.12

43.60

1.2

30.70

40.11

u/l

0.50

171

538

Hyperlipidaemia, other/unspecified

603

2947

1.86

43.35

1.3

34.34

37.00

u/l

0.26

520

2534

Ischaemic heart disease, wide definition

1083

4180

1.61

43.15

1.2

1.3

30.02

33.79

u/l

0.52

951

3627

Codes for special purposes

754

4364

1.73

43.10

1.3

50.52

33.07

u/l

2.08

685

3758

Provisional assignment of new diseases of uncertain etiology

753

4358

1.73

43.07

1.3

50.56

33.00

u/l

2.10

684

3752

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

430

991

2.20

42.80

1.2

1.3

35.39

25.13

u/l

0.61

377

836

Cholelithiasis, broad definition with cholecystitis

1168

4988

1.57

42.75

1.2

1.3

35.43

32.53

u/l

0.25

1016

4333

Hypopituitarism

158

482

3.40

42.45

1.2

32.53

38.19

u/l

0.10

134

416

COPD differential diagnosis

975

2962

1.66

42.28

1.3

39.67

25.33

u/l

1.99

859

2568

ILD differential diagnosis

974

2961

1.66

42.12

1.3

39.71

25.33

u/l

1.99

858

2567

AV-block

300

1086

2.40

41.54

1.3

1.4

26.93

35.52

u/l

1.22

266

912

Presence of cardiac and vascular implants and grafts

708

2979

1.77

41.51

1.2

1.3

29.30

33.13

u/l

0.55

625

2572

Iron deficiency anaemia secondary to blood loss (chronic)

285

1202

2.42

41.33

1.3

62.95

36.73

u/l

0.99

247

1037

Diseases of the skin and subcutaneous tissue

1265

4123

1.55

41.32

1.3

39.96

29.61

u/l

1.46

1100

3587

Autoimmune diseases excluding thyroid diseases

1347

4832

1.52

41.08

1.3

43.96

29.79

u/l

2.21

1202

4183

Cholelithiasis

1118

4905

1.57

40.83

1.2

1.3

32.68

32.88

u/l

0.02

972

4256

Factors influencing health status and contact with health services

400

914

2.22

40.79

1.3

41.14

21.98

u/l

1.51

350

789

Major coronary heart disease event excluding revascularizations

874

3497

1.67

40.49

1.3

30.55

34.87

u/l

0.64

768

3008

Asthma

936

2936

1.66

40.41

1.2

1.3

29.99

25.47

u/l

0.60

847

2546

Intestinal infectious diseases

1231

6063

1.52

39.73

1.3

45.21

30.24

u/l

2.25

1085

5286

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

158

333

3.39

38.99

1.2

1.3

43.28

45.61

u/l

0.05

142

287

Myocardial infarction

725

2966

1.73

38.81

1.2

1.3

32.31

36.59

u/l

0.52

642

2546

Oxycodone

591

2821

1.81

38.68

1.7

1.3

58.32

29.84

u/l

6.32

520

2437

Non-Hodgkin lymphoma, all, including Hilmo

217

831

2.67

38.67

1.3

1.2

80.89

19.55

u/l

5.32

192

700

Certain infectious and parasitic diseases, including avohilmo

902

2756

1.65

38.33

1.3

42.85

24.04

u/l

2.93

790

2393

Neurological diseases

1004

3161

1.60

38.19

1.3

33.88

34.90

u/l

0.07

881

2769

Osteopathies and chondropathies

780

4325

1.66

38.17

1.3

34.90

32.45

u/l

0.26

689

3738

Other antidepressants

1349

4628

1.50

37.85

1.3

36.83

32.70

u/l

0.39

1160

4067

Exclusions for E4_PCOS_BROAD

273

1175

2.37

37.70

1.2

30.49

36.03

u/l

0.18

237

1030

Autoimmune diseases excluding thyroid diseases, strict definition

1284

4671

1.50

37.37

1.3

44.41

30.08

u/l

2.10

1143

4038

Diarrhoea and gastroenteritis of presumed infectious origin

917

5192

1.59

37.20

1.3

42.03

29.18

u/l

1.63

805

4517

Cardiodefibrillation

587

3336

1.78

36.96

1.3

30.55

36.82

u/l

0.93

527

2864

Asthma (mode)

910

2961

1.62

36.79

1.2

1.3

29.64

25.33

u/l

0.56

829

2567

Ulcer of lower limb, not elsewhere classified

280

1235

2.32

36.78

1.3

39.45

37.42

u/l

0.10

243

1067

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

944

5260

1.57

36.68

1.3

41.20

32.72

u/l

1.23

822

4569

Persons encountering health services for other counselling and medical advice, not elsewhere classified

1421

5177

1.47

36.38

1.3

38.69

29.76

u/l

1.34

1271

4499

Infections of the skin and subcutaneous tissue

797

4859

1.63

36.25

1.2

1.3

31.19

32.49

u/l

0.11

700

4237

Peripheral artery disease

690

3231

1.71

36.20

1.2

1.3

37.19

36.36

u/l

0.06

599

2780

Autoimmune diseases

1397

4845

1.47

36.05

1.3

36.93

29.72

u/l

1.15

1237

4196

Disorders of calcium metabolism

134

410

3.38

35.93

1.3

29.10

38.82

u/l

0.66

121

352

Disorders of thyroid, IBD co-morbidities

188

450

2.89

35.93

1.3

24.00

39.06

u/l

0.81

176

397

Asthma (only as main-diagnosis)

852

2936

1.63

35.65

1.3

28.84

25.47

u/l

0.40

766

2546

Pacemaker

592

3171

1.76

35.41

1.3

25.74

39.37

u/l

4.57

524

2710

Soft tissue disorders

1248

4290

1.50

35.28

1.3

28.61

33.70

u/l

0.83

1094

3728

Chronic gastritis

416

2164

1.95

35.12

1.4

1.3

44.00

33.90

u/l

0.53

369

1853

Type 1 diabetes

321

1518

2.14

35.06

1.2

1.4

32.02

33.13

u/l

0.05

289

1315

Obesity, other/unspecified

419

2183

1.94

35.06

1.2

1.3

34.60

30.74

u/l

0.18

372

1909

Failure and rejection of transplanted organs and tissues

7.11

34.76

1.4

1.2

139.18

31.18

u/l

1.30

Other disorders of skin and subcutaneous tissue

988

5454

1.54

34.76

1.3

41.80

32.47

u/l

1.11

850

4748

Disorders of lens

916

3613

1.59

34.60

1.2

1.3

35.58

31.50

u/l

0.42

798

3152

COPD (mode)

461

1919

1.90

34.38

1.2

1.3

30.75

27.73

u/l

0.32

395

1639

Spondylopathies

1052

4079

1.54

34.32

1.3

34.06

31.80

u/l

0.18

933

3532

Other arrhythmias

740

3370

1.65

34.26

1.3

25.22

29.19

u/l

0.40

663

2920

Myocardial infarction, strict

672

2831

1.70

34.05

1.2

1.3

31.42

36.74

u/l

0.68

599

2429

Other CVD (FINNGEN)

161

415

3.01

33.87

1.1

1.6

32.97

32.61

u/l

0.02

149

351

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

458

2491

1.86

33.65

1.2

36.64

32.21

u/l

0.18

413

2156

Cardiomyopathies, Primary/intrinsic

206

826

2.55

33.48

1.2

1.4

17.62

30.57

u/l

2.87

187

702

Chronic periodontitis, complicated

809

5007

1.59

33.29

1.3

29.25

33.29

u/l

0.56

697

4391

Obesity related asthma

497

2788

1.80

33.02

1.3

32.71

31.02

u/l

0.09

446

2401

Low back pain

981

4337

1.54

33.00

1.3

32.65

32.44

u/l

0.02

858

3772

1428

5054

1.44

32.99

1.3

38.93

30.79

u/l

1.26

1253

4395

Benign neoplasms

1210

4471

1.48

32.81

1.3

33.03

31.06

u/l

0.19

1058

3911

Benign neoplasm of colon, rectum, anus and anal canal

913

5033

1.55

32.70

1.3

34.62

34.71

u/l

0.01

796

4366

Other autoimmune haemolytic anaemias

7.11

32.69

1.4

1.2

59.50

24.65

u/l

1.50

Intestinal infectious diseases, including avohilmo, including avohilmo

1457

5730

1.42

32.26

1.3

41.68

30.13

u/l

1.84

1287

4994

Symptoms and signs involving the urinary system

1027

5181

1.51

31.97

1.3

29.65

33.03

u/l

0.57

880

4521

Disorders of choroid and retina

1108

5263

1.48

31.74

1.3

40.57

31.46

u/l

1.12

954

4598

Diseases of liver

513

2940

1.77

31.72

1.3

32.97

31.13

u/l

0.14

457

2538

Cardiomyopathy (excluding other)

210

872

2.46

31.68

1.2

1.4

17.68

29.53

u/l

2.69

191

742

Diseases of the digestive system

660

4015

1.65

31.60

1.2

1.3

35.14

33.45

u/l

0.16

582

3462

Other malignant neoplasms of skin (=non-melanoma skin cancer), including Hilmo

592

2338

1.72

31.55

1.4

1.2

36.67

20.08

u/l

3.45

511

2008

GI-bleeding

499

2844

1.78

31.44

1.2

1.3

38.34

34.32

u/l

0.34

441

2440

Chronic apical periodontitis

1395

5513

1.43

31.31

1.3

39.49

30.29

u/l

1.30

1223

4802

Other diseases of the digestive system

498

2842

1.77

31.26

1.2

1.3

38.31

34.41

u/l

0.32

437

2440

Gingivitis and periodontal diseases

1272

4540

1.46

31.23

1.3

32.78

31.27

u/l

0.14

1113

3954

Testicular dysfunction

104

299

3.64

30.96

1.3

15.62

46.89

u/l

2.07

255

Other malignant neoplasms of skin (=non-melanoma skin cancer)

569

2249

1.73

30.93

1.3

1.2

38.15

20.10

u/l

3.74

488

1932

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

812

5148

1.56

30.87

1.3

46.77

31.54

u/l

1.57

713

4473

Other blood glucose lowering drugs, excl. Insulins

255

1164

2.23

30.86

1.3

25.34

40.17

u/l

1.85

222

997

Nerve, nerve root and plexus disorders

1358

5750

1.43

30.84

1.3

29.43

33.08

u/l

0.51

1197

5001

Infarction of spleen

10.70

30.84

1.4

1.2

66.21

21.41

u/l

1.20

Gastro-oesophageal reflux disease

891

4935

1.53

30.84

1.3

30.16

29.97

u/l

0.02

763

4301

Testicular hypofunction

272

3.79

30.80

1.3

15.65

41.82

u/l

1.55

234

Pain (limb, back, neck, head abdominally)

915

2965

1.56

30.71

1.3

34.47

33.32

u/l

0.09

809

2554

All influenza

370

1941

1.93

30.47

1.5

1.3

63.02

23.65

u/l

3.03

330

1663

Atherosclerosis, excluding cerebral and coronary sclerosis

636

3037

1.66

30.42

1.3

36.83

36.48

u/l

0.02

544

2616

Persons encountering health services in other circumstances

534

3094

1.72

30.40

1.3

44.01

29.27

u/l

0.92

456

2671

Angina pectoris

770

3234

1.59

30.19

1.2

1.3

30.99

35.59

u/l

0.54

679

2786

Diabetic maculopathy, excluding more controls

177

694

2.61

30.19

1.2

1.3

22.59

45.95

u/l

1.92

157

601

Diseases of the musculoskeletal system and connective tissue

616

1820

1.71

29.94

1.3

34.35

29.49

u/l

0.39

536

1603

Calcific aortic valvular stenosis

479

2632

1.78

29.93

1.2

1.3

42.02

36.75

u/l

0.51

424

2245

Calcific aortic valvular stenosis, operated

479

2632

1.78

29.93

1.2

1.3

42.02

36.75

u/l

0.51

424

2245

Calcific aortic valvular stenosis, including rheumatic fever

480

2640

1.77

29.78

1.2

1.3

41.93

36.76

u/l

0.50

425

2251

Calcific aortic valvular stenosis, diagnosis (helper)

478

2629

1.77

29.77

1.2

1.3

42.08

36.78

u/l

0.51

423

2243

Operations 2 for CAVS

478

2629

1.77

29.77

1.2

1.3

42.08

36.78

u/l

0.51

423

2243

Other diseases of liver

285

1380

2.10

29.62

1.4

1.3

23.73

35.31

u/l

1.03

252

1186

Malignant neoplasm of skin

605

2463

1.68

29.20

1.3

1.2

44.27

19.66

u/l

3.29

525

2117

L04AA Selective immunosuppressants

316

1597

2.01

29.14

1.3

35.61

32.44

u/l

0.23

297

1379

Senile cataract

843

3335

1.55

28.85

1.2

1.3

36.81

31.66

u/l

0.53

736

2895

Type 1 diabetes, wide definition, subgroup 1

260

1228

2.14

28.66

1.2

1.3

35.34

33.94

u/l

0.05

232

1070

Malignant neoplasm of skin, including Hilmo

628

2568

1.65

28.57

1.3

1.2

43.79

19.40

u/l

3.44

546

2212

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

1234

5493

1.43

28.54

1.3

39.87

30.51

u/l

1.06

1078

4785

Other bacterial intestinal infections

283

1387

2.07

28.48

1.4

1.3

60.50

33.96

u/l

1.74

255

1195

Other medical care

675

3570

1.60

28.14

1.7

1.2

77.42

28.31

u/l

9.46

606

3074

Symptoms and signs involving the digestive system and abdomen

1260

4446

1.43

27.88

1.2

1.3

30.82

32.09

u/l

0.13

1114

3855

Enterocolitis due to Clostridium difficile

193

819

2.41

27.86

1.4

1.2

62.28

35.86

u/l

1.57

171

701

Volume depletion

169

677

2.55

27.63

1.1

1.3

22.64

47.54

u/l

2.76

138

578

Diseases of the respiratory system

755

2401

1.59

27.56

1.2

1.3

42.82

26.18

u/l

1.82

665

2077

Hyperkalaemia

126

436

2.98

27.54

1.3

45.79

46.67

u/l

0.02

109

371

Basal cell carcinoma

541

2192

1.70

27.43

1.3

1.2

44.22

20.09

u/l

3.10

466

1878

Kidney transplant status

109

348

3.25

27.43

1.3

39.37

33.95

u/l

0.18

104

295

Asthma-related infections

755

4820

1.54

27.14

1.3

40.40

32.78

u/l

0.65

677

4170

Asthma, hospital admission 2, infections

755

4820

1.54

27.14

1.3

40.40

32.78

u/l

0.65

677

4170

Arthropathies

1050

3637

1.47

26.85

1.2

1.3

35.17

30.27

u/l

0.42

922

3178

Chronic lower respiratory diseases

1459

5595

1.38

26.82

1.2

1.3

35.28

32.36

u/l

0.28

1293

4874

Venous thromboembolism

737

4639

1.54

26.75

1.3

45.55

33.74

u/l

1.13

647

4007

Abnormalities of heart beat

452

2541

1.74

26.69

1.2

1.3

37.91

32.42

u/l

0.25

394

2173

Symptoms and signs involving cognition, perception, emotional state and behaviour

1198

5688

1.41

26.64

1.3

33.78

31.70

u/l

0.25

1053

4955

Hernia

1161

5455

1.42

26.54

1.3

37.52

30.89

u/l

0.82

1024

4744

Viral pneumonia

207

925

2.28

26.45

1.3

58.28

27.39

u/l

1.94

188

798

Other dorsopathies, not elsewhere classified

1201

4404

1.42

26.40

1.3

29.63

32.65

u/l

0.41

1061

3829

Cerebrovascular diseases

1003

4803

1.46

26.38

1.3

34.89

34.37

u/l

0.05

875

4178

Basal cell carcinoma, including Hilmo

554

2267

1.67

26.36

1.3

1.2

45.03

20.24

u/l

3.27

481

1945

Agranulocytosis

167

681

2.50

26.30

1.3

1.2

127.12

33.19

u/l

4.56

149

588

Intracranial trauma

632

2671

1.61

26.08

1.3

33.93

35.30

u/l

0.08

555

2349

Dizziness and giddiness

960

5143

1.46

26.01

1.3

31.29

32.39

u/l

0.13

843

4461

Hypertensive Renal Disease

212

3.86

25.99

1.2

1.3

16.29

59.47

u/l

2.74

174

Dorsalgia

1174

4390

1.42

25.98

1.3

31.45

32.74

u/l

0.15

1039

3816

Bacterial intestinal infections, IBD co-morbidities

283

1440

2.00

25.71

1.4

1.3

60.69

34.82

u/l

1.69

255

1242

Myocardial infarction, without ST-elevation

611

3490

1.60

25.46

1.3

34.21

35.74

u/l

0.14

532

3002

Type 1 diabetes, wide definition

264

1316

2.03

25.23

1.2

1.3

34.89

33.79

u/l

0.04

236

1143

Cholecystectomy

888

5163

1.47

25.22

1.3

36.36

33.37

u/l

0.21

781

4473

Explicit bacterial Sepsis

181

784

2.36

24.95

1.4

1.3

63.37

36.06

u/l

1.36

171

683

Lower back pain or/and sciatica

1319

5979

1.38

24.85

1.3

34.56

31.98

u/l

0.31

1172

5206

Nonalcoholic fatty liver disease

167

700

2.44

24.83

1.4

1.3

17.21

38.04

u/l

2.70

147

604

Other bacterial intestinal infections, including avohilmo

335

1823

1.86

24.79

1.3

52.79

30.46

u/l

1.74

302

1578

Other retinal disorders

880

4572

1.47

24.77

1.3

42.39

32.94

u/l

0.91

752

3973

Explicit bacterial Sepsis, including avohilmo

183

799

2.34

24.76

1.4

1.3

62.75

35.81

u/l

1.36

173

696

Benign neoplasm: Colon

761

4793

1.50

24.36

1.3

35.86

35.47

u/l

0.03

664

4146

Other specific joint derangements/joint disorders

841

3539

1.49

24.28

1.2

1.3

27.53

30.21

u/l

0.29

746

3095

DVT of lower extremities and pulmonary embolism

579

3668

1.59

23.95

1.3

50.16

32.93

u/l

1.44

509

3148

Dental operations

802

2746

1.51

23.93

1.3

45.37

31.34

u/l

1.50

684

2365

Caries of dentine, including avohilmo

967

3418

1.45

23.82

1.3

39.67

32.66

u/l

0.62

844

2953

Use of hypnotics and sedatives

1308

5475

1.37

23.69

1.4

1.3

35.36

31.52

u/l

0.44

1132

4790

Diseases of the eye and adnexa

884

3011

1.48

23.63

1.3

30.49

30.27

u/l

0.02

770

2650

Idiopathic thrombocytopenic purpura

190

3.91

23.58

1.3

1.2

87.55

35.06

u/l

0.98

163

Diarrhoea and gastroenteritis of presumed infectious origin, including avohilmo

1230

5747

1.38

23.49

1.3

38.88

29.88

u/l

1.10

1078

5011

Bacterial pneumoniae

540

2971

1.61

23.35

1.3

66.95

25.83

u/l

4.55

491

2545

Diabetic nephropathy, excluding more controls

309

1352

1.90

23.30

1.2

26.91

24.91

u/l

0.18

277

1147

Nausea and vomiting

360

1988

1.78

23.23

1.5

1.3

37.82

35.43

u/l

0.14

312

1687

Headache

737

3810

1.50

23.14

1.3

34.98

26.73

u/l

0.79

642

3294

Syncope and collapse

569

3016

1.59

23.07

1.2

1.3

33.54

27.76

u/l

0.66

478

2583

Presence of other functional implants

784

3630

1.49

23.00

1.3

44.87

31.59

u/l

1.26

653

3148

Unspecified haematuria

611

3213

1.56

22.99

1.3

33.33

34.98

u/l

0.16

520

2797

Abdominal and pelvic pain

1221

4446

1.39

22.94

1.2

1.3

30.28

32.09

u/l

0.19

1091

3855

Gonarthrosis

824

3158

1.48

22.93

1.3

29.71

31.42

u/l

0.15

718

2743

Pulmonary heart disease, diseases of pulmonary circulation

451

2731

1.67

22.93

1.3

52.59

34.36

u/l

1.32

396

2342

Adjustment and management of implanted device

289

1542

1.90

22.89

1.2

28.34

31.28

u/l

0.29

253

1316

Gonarthrosis [arthrosis of knee](FG)

949

3811

1.44

22.86

1.2

1.3

29.12

29.44

u/l

0.03

827

3299

Arthrosis

884

3332

1.46

22.75

1.2

1.3

34.13

31.17

u/l

0.20

769

2897

Other intervertebral disc disorders

1006

4240

1.42

22.71

1.3

34.23

32.29

u/l

0.14

896

3677

Other acute lower respiratory infections

682

4326

1.51

22.68

1.3

42.50

31.21

u/l

1.32

597

3751

Second line medication for Crohn's disease

701

4698

1.50

22.67

1.3

45.08

30.26

u/l

2.83

639

4082

Spinal stenosis

696

3406

1.52

22.64

1.3

30.38

33.27

u/l

0.31

621

2932

Diseases of pulp and periapical tissues and dental caries

820

2846

1.49

22.61

1.2

1.3

44.64

32.95

u/l

0.99

711

2443

Exclusions for E4_PCOS_CONSORTIUM

728

3025

1.51

22.58

1.2

1.3

35.53

34.01

u/l

0.08

628

2663

Vocal cord dysfunction

147

529

2.47

22.34

1.3

1.4

37.59

29.29

u/l

0.28

124

453

Diseases of pulp and periapical tissues, including avohilmo

1246

4719

1.37

22.19

1.3

37.70

31.28

u/l

0.74

1086

4100

Nonischemic cardiomyopathy

172

768

2.29

22.14

1.4

1.3

17.99

35.05

u/l

2.87

155

662

Coxarthrosis [arthrosis of hip](FG)

723

3338

1.50

22.10

1.3

42.36

31.88

u/l

0.80

628

2884

Other disorders of urethra and urinary system

833

3999

1.46

22.07

1.3

25.91

37.82

u/l

3.88

731

3449

Other diseases of urinary system

1190

4877

1.38

21.96

1.3

30.95

34.15

u/l

0.44

1037

4232

Hypo-osmolality and hyponatraemia

256

1320

1.95

21.91

1.2

1.3

32.38

36.95

u/l

0.34

219

1128

Diseases of oral cavity, salivary glands and jaws

737

2532

1.51

21.89

1.3

41.53

30.71

u/l

1.02

630

2186

Other diseases of pleura

642

3691

1.52

21.88

1.4

1.3

40.65

35.68

u/l

0.47

542

3196

Early onset COPD, excluding more controls

279

1493

1.89

21.78

1.4

1.3

28.97

23.39

u/l

0.58

237

1282

Asthma-related pneumonia or sepsis

494

3090

1.61

21.71

1.4

1.3

51.75

33.99

u/l

1.26

447

2646

Asthma, hospital admissions 3, pneumonia

494

3090

1.61

21.71

1.4

1.3

51.75

33.99

u/l

1.26

447

2646

Asthma-related pneumonia

493

3083

1.61

21.70

1.4

1.3

51.65

34.03

u/l

1.24

446

2639

Dorsopathies

1194

4414

1.38

21.60

1.3

32.86

32.71

u/l

0.01

1053

3839

Solid cancers, including Hilmo

875

3543

1.45

21.59

1.4

1.2

43.87

18.06

u/l

4.74

776

3082

Dental caries, including avohilmo

897

3192

1.45

21.59

1.2

1.3

41.78

33.11

u/l

0.75

781

2751

Bacterial pneumonia, not elsewhere classified

509

2816

1.60

21.58

1.3

64.95

26.20

u/l

4.27

463

2407

L04AX Other immunosuppressants

679

4575

1.49

21.48

1.3

45.28

30.28

u/l

2.81

618

3971

Viral hepatitis, IBD co-morbidity

179

3.75

21.29

1.3

1.1

46.89

40.76

u/l

0.10

147

Bronchitis

1308

5854

1.35

21.25

1.3

35.85

32.06

u/l

0.52

1144

5106

Phlebitis and thrombophlebitis (not including DVT)

316

1778

1.80

21.07

1.3

1.2

44.93

32.47

u/l

0.59

275

1528

Amputation

181

843

2.19

21.07

1.2

1.3

35.96

39.79

u/l

0.20

164

720

Missing teeth due to accident, extraction or parodontitis

822

5141

1.44

21.02

1.2

1.3

32.96

33.99

u/l

0.10

693

4499

Diaphragmatic hernia

484

3052

1.60

20.94

1.4

1.3

38.26

34.53

u/l

0.25

429

2623

Bacterial pneumonia (organism specified)

598

3570

1.53

20.83

1.3

69.03

29.44

u/l

4.82

544

3062

Disorders resulting from impaired renal tubular function

264

3.23

20.53

1.1

1.3

26.46

36.72

u/l

0.45

228

Implicit fungal Sepsis, including avohilmo

121

481

2.58

20.29

1.3

41.85

31.61

u/l

0.45

102

412

Pain in joint

693

2872

1.49

20.21

1.3

29.30

33.19

u/l

0.35

618

2479

Streptococcal septicaemia

155

690

2.30

20.20

1.4

1.2

59.44

30.00

u/l

1.58

147

590

Visual disturbances and blindness

651

4408

1.49

20.12

1.2

1.3

31.65

34.08

u/l

0.21

569

3823

Other disorders of skin and subcutaneous tissue, not elsewhere classified

213

1072

2.02

20.12

1.2

35.53

37.65

u/l

0.08

182

926

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

721

4973

1.46

20.08

1.3

40.40

33.31

u/l

0.56

631

4324

Symptoms and signs involving the skin and subcutaneous tissue

870

5867

1.41

20.02

1.3

43.29

31.47

u/l

1.36

777

5093

Cutaneous abscess, furuncle and carbuncle

348

2042

1.72

20.02

1.2

1.3

35.58

29.37

u/l

0.35

309

1781

Extracorporeal dialysis

118

469

2.59

19.90

1.1

1.3

28.07

45.85

u/l

1.00

109

398

Abnormal findings on diagnostic imaging of lung

661

4263

1.48

19.86

1.4

1.3

44.11

34.60

u/l

0.98

579

3689

Constipation

1095

5468

1.36

19.78

1.3

36.92

32.20

u/l

0.48

955

4757

Other diseases of arteries and capillaries

148

653

2.31

19.70

1.2

47.88

37.25

u/l

0.25

132

557

Vascular disorders of the intestines

124

507

2.50

19.61

1.4

1.3

67.43

41.06

u/l

0.62

113

430

Amputation of toe

139

600

2.38

19.57

1.2

1.3

37.43

43.45

u/l

0.26

127

515

Peripheral arterial reconstruction

273

1509

1.84

19.44

1.3

34.22

40.20

u/l

0.43

244

1299

Coxarthrosis

659

2871

1.49

19.41

1.3

43.98

32.77

u/l

0.76

565

2488

Cytomegaloviral disease

155

3.93

19.39

1.5

1.2

91.54

28.14

u/l

1.24

132

Cytomegaloviral disease, including avohilmo

155

3.92

19.38

1.5

1.2

91.54

28.14

u/l

1.24

132

Other disorders of kidney and ureter

208

1059

2.00

19.10

1.2

1.3

22.58

37.83

u/l

2.23

184

917

Personality disorders, excluding more controls

269

1481

1.83

19.08

1.2

1.3

30.42

29.83

u/l

0.03

237

1311

Other diseases of hard tissues of teeth

711

2511

1.48

19.06

1.2

1.3

40.09

30.60

u/l

0.77

614

2168

Streptococcal septicaemia, including avohilmo

155

708

2.23

19.00

1.4

1.2

59.44

29.54

u/l

1.62

147

605

Other chronic obstructive pulmonary disease, including avohilmo

741

4254

1.44

19.00

1.3

28.81

35.32

u/l

1.29

639

3679

Glomerulonephritis

157

721

2.22

19.00

1.2

1.3

25.16

41.61

u/l

1.59

147

626

COPD

630

3472

1.49

18.88

1.3

29.70

35.10

u/l

0.90

543

2989

Other disorders of ear

1118

5378

1.35

18.81

1.3

34.82

30.70

u/l

0.44

960

4695

Cytomegalovirus infection, IBD co-morbidity

154

3.89

18.79

1.5

1.2

91.54

20.94

u/l

1.51

133

Chronic ulcer of skin, not elsewhere classified

122

506

2.47

18.75

1.2

1.3

25.74

34.65

u/l

0.69

109

427

Diabetic nephropathy

311

1787

1.75

18.69

1.2

26.92

28.89

u/l

0.17

279

1558

Acute bronchitis

516

3323

1.53

18.60

1.3

40.32

31.10

u/l

0.82

445

2865

Hyperkinetic disorders, excluding more controls

107

386

2.61

18.56

1.2

11.14

27.54

u/l

1.64

343

Visual disturbances

598

4061

1.48

18.39

1.2

1.3

30.59

34.03

u/l

0.29

522

3518

Pneumonia due to other infectious organisms, not elsewhere classified

209

3.37

18.36

1.5

1.2

89.64

23.72

u/l

2.46

181

Respiratory insufficiency

132

570

2.35

18.35

1.2

1.3

54.38

26.90

u/l

1.10

102

484

Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity

128

548

2.39

18.32

1.3

1.2

79.77

42.71

u/l

0.91

112

472

Secondary and unspecified malignant neoplasm of lymph nodes

123

517

2.43

18.31

1.3

1.2

113.85

18.73

u/l

2.27

109

441

Care involving use of rehabilitation procedures

750

4765

1.42

18.31

1.4

1.2

40.76

26.51

u/l

1.64

688

4127

Pain, not elsewhere classified

333

1982

1.69

18.18

1.2

1.3

42.61

26.34

u/l

0.70

308

1689

Exposure to unspecified factor

1200

6178

1.33

18.16

1.3

36.94

31.84

u/l

0.62

1055

5392

Hernia of abdominal wall

600

4090

1.48

18.14

1.2

1.3

37.28

31.51

u/l

0.44

522

3561

Asthma (diagnoses ohter than nonallergic)

1024

6143

1.35

18.12

1.3

35.09

32.69

u/l

0.20

924

5333

Artrosis, including avohilmo

992

3976

1.37

18.07

1.2

1.3

31.66

33.21

u/l

0.12

862

3477

Concussion

521

2655

1.53

17.98

1.3

28.59

35.11

u/l

0.60

453

2334

Shoulder lesions

908

3943

1.39

17.92

1.3

33.62

33.20

u/l

0.03

811

3418

Other joint disorders

955

3633

1.38

17.60

1.2

1.3

29.34

30.30

u/l

0.08

833

3174

Other and unspecified dermatitis

634

4392

1.45

17.58

1.2

1.3

42.73

30.87

u/l

0.93

558

3807

Other functional intestinal disorders

543

3307

1.50

17.55

1.3

40.45

33.18

u/l

0.41

483

2855

Ventral hernia

323

1941

1.68

17.12

1.2

1.3

35.52

33.89

u/l

0.07

275

1671

Ischaemic Stroke, excluding all haemorrhages

749

3926

1.41

17.08

1.2

1.3

35.64

36.23

u/l

0.04

641

3389

Dermatitis

756

5312

1.40

17.01

1.2

1.3

38.84

31.94

u/l

0.55

671

4612

Other diseases of upper respiratory tract

1305

5223

1.31

17.00

1.3

34.68

32.95

u/l

0.15

1147

4544

Other/unspecified cytomegaloviral diseases

133

3.96

16.89

1.5

1.2

102.61

18.39

u/l

1.59

116

Depression or dysthymia

811

3174

1.40

16.86

1.2

1.3

28.87

34.16

u/l

0.46

698

2789

Peripheral artery operations in Hilmo

200

1049

1.94

16.84

1.2

1.3

38.38

38.03

u/l

0.01

179

894

Squamous cell neoplasms and carcinomas of the skin, including Hilmo

167

814

2.06

16.77

1.5

1.2

50.96

20.84

u/l

2.58

147

691

Disorders of parathyroid gland

273

1560

1.75

16.66

1.3

1.2

31.77

38.78

u/l

0.61

250

1331

Fall on same level

1315

5411

1.30

16.60

1.3

36.51

30.28

u/l

0.87

1159

4720

Benzodiazepine use

1181

6101

1.31

16.55

1.3

31.18

33.31

u/l

0.29

1010

5347

Solid cancers

825

3494

1.39

16.54

1.4

1.2

45.69

17.96

u/l

4.87

725

3042

Diseases of the ear and mastoid process

1300

5020

1.30

16.44

1.2

1.3

29.85

30.12

u/l

0.03

1139

4391

Secondary right heart disease

294

2.84

16.43

1.2

1.3

41.36

39.19

u/l

0.06

253

Abnormality of white blood cells, not elsewhere classified

5.69

16.42

1.3

1.2

69.29

20.83

u/l

1.40

Disorders of eyelid, lacrimal system and orbit

1032

5703

1.33

16.31

1.3

27.91

34.12

u/l

1.34

890

4975

Other cataract

558

2828

1.48

16.16

1.3

43.32

34.17

u/l

0.59

483

2454

Stroke, including SAH

817

4278

1.38

16.08

1.2

1.3

36.22

35.45

u/l

0.06

697

3705

Cough

459

2830

1.52

16.03

1.2

1.3

26.79

32.52

u/l

0.94

401

2428

Hypercalcemia

316

2.74

15.93

1.3

31.01

37.38

u/l

0.29

269

Sulfonylureas

441

2290

1.54

15.89

1.2

1.4

28.99

41.49

u/l

1.98

377

1975

Other chronic obstructive pulmonary disease

595

3386

1.45

15.84

1.3

30.09

35.20

u/l

0.78

511

2912

Later onset COPD, excluding more controls

293

1322

1.71

15.78

1.2

1.4

29.37

32.42

u/l

0.27

255

1114

Pulmonary embolism

392

2520

1.57

15.76

1.3

47.95

34.92

u/l

0.82

345

2158

Idiopathic gout

160

799

2.04

15.67

1.4

1.3

38.42

40.19

u/l

0.05

145

688

Elevated blood glucose level

127

580

2.23

15.66

1.2

24.56

42.65

u/l

1.25

109

500

Disease of hard tissues of teeth, NOS

667

2448

1.43

15.63

1.3

33.53

30.49

u/l

0.19

582

2121

Stroke, excluding SAH

783

4116

1.38

15.62

1.2

1.3

36.63

36.14

u/l

0.04

665

3560

Disorders of the thyroid gland

1080

5340

1.32

15.54

1.3

29.82

34.35

u/l

0.55

958

4632

Migraine

468

2417

1.51

15.53

1.3

19.16

34.47

u/l

3.73

420

2104

Special screening examination for other diseases and disorders

145

698

2.10

15.51

1.2

23.60

25.67

u/l

0.13

136

580

Squamous cell neoplasms and carcinomas of the skin

134

628

2.17

15.42

1.4

1.2

52.48

19.71

u/l

2.67

120

526

Osteoporosis

338

1934

1.62

15.39

1.3

1.2

42.48

38.13

u/l

0.23

303

1636

Pulmonary heart disease

392

2536

1.56

15.34

1.3

47.95

35.43

u/l

0.78

345

2171

Osteomyelitis

112

491

2.34

15.30

1.4

1.3

31.47

43.53

u/l

0.54

101

425

Unstable angina pectoris

481

2539

1.50

15.20

1.4

1.3

31.65

36.91

u/l

0.57

421

2161

Gastroduodenal ulcer

348

2189

1.60

15.19

1.4

1.3

50.16

34.53

u/l

0.65

302

1867

Acute sinusitis

571

3625

1.44

15.02

1.3

34.71

30.08

u/l

0.43

504

3157

Diseases of male genital organs

698

2502

1.41

14.98

1.3

32.54

31.91

u/l

0.04

616

2198

Sequelae of external causes of morbidity and mortality

338

2129

1.60

14.91

1.4

1.3

62.91

32.01

u/l

1.31

307

1838

Enlarged lymph nodes

199

1085

1.85

14.88

1.2

88.25

30.19

u/l

1.84

184

929

Symptoms and signs concerning food and fluid intake

149

736

2.05

14.88

1.6

1.2

25.61

31.89

u/l

0.45

138

625

500

3394

1.47

14.87

1.2

1.3

35.23

31.35

u/l

0.21

448

2926

Amiodarone users

170

884

1.96

14.86

1.2

1.3

22.85

41.73

u/l

2.79

153

760

L01XE Protein kinase inhibitors

400

2.47

14.78

1.4

1.3

89.33

40.64

u/l

1.09

350

Polycystic ovarian syndrome, consortium definition

609

2444

1.43

14.68

1.2

23.99

35.19

u/l

1.94

517

2134

Disorders of iron metabolism

4.21

14.46

1.2

14.70

37.80

u/l

1.04

Fungal Sepsis

280

2.75

14.44

1.3

62.53

31.69

u/l

0.96

245

Gastric ulcer

243

1421

1.73

14.36

1.4

1.3

62.93

35.74

u/l

0.88

213

1212

Migraine with aura

225

1286

1.76

14.31

1.2

1.3

19.42

35.54

u/l

1.70

195

1107

Non-allergic asthma (mode), excluding more controls

203

1117

1.82

14.26

1.3

25.50

25.85

u/l

0.02

189

949

Viral pneumonia (unknown virus, not influenza)

104

457

2.32

14.13

1.4

1.3

48.55

41.47

u/l

0.17

394

Selective serotonin reuptake inhibitors

1150

4636

1.29

14.08

1.2

1.3

31.10

32.66

u/l

0.13

982

4074

Autoimmune diseases related-to ILD

969

6197

1.31

14.07

1.2

1.3

34.71

31.68

u/l

0.31

859

5392

Extreme obesity with alveolar hypoventilation

273

2.75

14.04

1.3

22.68

27.81

u/l

0.28

232

Psychiatric diseases

1145

4443

1.30

14.03

1.3

28.80

33.65

u/l

0.81

1003

3881

Other pulmonary heart/vessel disease

331

2.58

14.03

1.2

1.3

64.65

42.30

u/l

0.40

284

Hypothyroidism, other/unspecified

978

4920

1.31

13.80

1.3

27.89

34.49

u/l

1.28

863

4254

Osteoporosis with pathological fracture (FG)

100

437

2.33

13.75

1.2

1.3

30.47

29.62

u/l

0.05

375

Implicit fungal Sepsis

259

2.78

13.74

1.4

1.3

52.90

32.79

u/l

0.60

227

Other metabolic disorders

145

733

2.00

13.66

1.3

1.2

75.07

31.06

u/l

1.29

135

625

Polyneuropathies and other disorders of the peripheral nervous system

307

1933

1.61

13.65

1.3

34.68

34.30

u/l

0.02

275

1667

Hypothyroidism, strict autoimmune

782

3811

1.35

13.60

1.3

28.63

29.77

u/l

0.13

681

3271

Asthma/COPD (KELA code 203)

1077

5591

1.29

13.60

1.3

34.48

32.37

u/l

0.16

960

4872

Mood disorders, excluding more controls

1074

4889

1.30

13.59

1.2

1.3

29.64

33.36

u/l

0.55

949

4268

Asthma, hospital admissions , main diagnosis only

912

6066

1.31

13.49

1.3

34.11

32.78

u/l

0.09

817

5277

Other specified/unspecified arthritis

312

1976

1.59

13.46

1.5

1.3

28.67

32.51

u/l

0.34

280

1706

Dilated cardiomyopathy

189

1051

1.83

13.43

1.2

1.3

17.78

37.80

u/l

4.67

172

907

547

3486

1.42

13.42

1.3

37.08

38.68

u/l

0.12

483

2989

Postprocedural endocrine and metabolic disorders, not elsewhere classified

135

670

2.04

13.41

1.3

1.2

79.02

32.69

u/l

1.25

126

576

Other headache syndromes

419

2820

1.49

13.39

1.4

1.3

32.35

33.30

u/l

0.05

374

2442

Hypothyreosis and Thyroxine purchase for inclusion criteria

1013

5124

1.30

13.36

1.3

27.71

34.34

u/l

1.33

896

4435

DVT of lower extremities

250

1504

1.68

13.34

1.3

49.14

34.40

u/l

0.58

221

1288

Cardiomyopathy, other and unspecified

110

507

2.21

13.33

1.1

1.3

35.35

30.52

u/l

0.18

100

426

Other and unspecified polyneuropathies, also in other diseases

273

1681

1.64

13.33

1.3

30.67

34.80

u/l

0.32

247

1450

Valvular operations

178

975

1.85

13.20

1.3

1.4

35.64

32.85

u/l

0.16

155

829

Other disorders of lacrimal gland

419

2843

1.48

13.14

1.4

1.2

31.57

36.59

u/l

0.40

357

2456

Mood disorders

1148

5770

1.28

13.13

1.2

1.3

28.57

32.88

u/l

0.73

1012

5035

Mood [affective] disorders

1146

5769

1.28

13.13

1.2

1.3

28.60

32.77

u/l

0.70

1010

5035

Other systemic involvement of connective tissue (FG)

288

1767

1.61

13.11

1.2

1.3

33.59

31.91

u/l

0.09

254

1507

Misadventures to patients during surgical and medical care

190

1065

1.81

13.09

1.6

1.2

27.38

31.92

u/l

0.43

167

931

Vitreous haemorrhage

154

809

1.94

13.08

1.2

1.3

59.17

37.06

u/l

0.57

135

704

Gonarthrosis,primary

1103

5201

1.28

13.07

1.3

32.74

32.26

u/l

0.04

970

4525

Other arthritis (FG)

349

2284

1.54

13.03

1.5

1.3

28.03

30.34

u/l

0.21

312

1960

Sub-endpoint used in defining T1D endpoints

342

2191

1.55

13.03

1.2

1.3

32.00

32.07

u/l

0.00

305

1906

Other coagulation defects

101

454

2.26

13.02

1.7

1.3

23.15

26.45

u/l

0.26

390

Injuries to the head

1264

5962

1.26

12.98

1.3

32.40

32.82

u/l

0.04

1113

5200

Asthma, including avohilmo

1346

5931

1.25

12.90

1.3

31.01

33.36

u/l

0.25

1201

5156

Thiazolidinediones

159

848

1.90

12.90

1.2

1.3

24.47

39.02

u/l

1.83

142

727

Hyperparathyroidism

234

1384

1.69

12.77

1.3

1.2

33.44

37.61

u/l

0.28

215

1178

Other diseases of the respiratory system

276

1723

1.62

12.74

1.3

44.85

37.71

u/l

0.31

220

1485

Other respiratory disorders and diseases

276

1723

1.62

12.74

1.3

44.85

37.71

u/l

0.31

220

1485

Secondary and unspecified malignant neoplasm of lymph nodes, including Hilmo

183

1025

1.81

12.64

2.5

1.2

87.10

18.97

u/l

2.46

161

876

Malignant neoplasm of urinary organs, including Hilmo

143

742

1.95

12.58

1.7

1.2

48.76

18.10

u/l

1.18

127

631

Candidiasis, including avohilmo

332

2170

1.54

12.50

1.3

31.45

32.23

u/l

0.06

285

1886

Skin changes due to chronic exposure to nonionizing radiation

519

3344

1.42

12.47

1.3

38.30

39.05

u/l

0.05

458

2867

Cystitis

920

4205

1.31

12.44

1.3

32.11

36.71

u/l

0.57

808

3637

COPD related to multimorbidity

538

3256

1.41

12.36

1.2

1.3

29.29

36.67

u/l

1.25

462

2815

Retention of urine

464

2618

1.44

12.26

1.5

1.3

35.72

37.49

u/l

0.13

408

2276

Endocarditis

229

2.78

12.25

1.3

55.18

30.06

u/l

0.39

189

Carpal tunnel syndrome

704

4565

1.34

12.23

1.2

1.3

26.47

32.76

u/l

0.75

617

3951

Primary hyperparathyroidism

150

800

1.90

12.20

1.3

1.2

35.77

32.20

u/l

0.17

138

687

Cellulitis

280

1774

1.59

12.16

1.3

25.93

32.20

u/l

0.84

241

1538

Sequelae with surgical and medical care as external cause

265

1658

1.62

12.15

1.4

1.3

71.44

33.55

u/l

1.22

238

1434

Actinic keratosis

503

3257

1.42

12.10

1.3

38.55

39.54

u/l

0.06

442

2791

Certain disorders involving the immune mechanism

233

1417

1.66

11.99

1.2

1.3

49.88

34.75

u/l

0.49

215

1227

Osteonecrosis

460

2.20

11.86

1.5

1.3

53.54

36.15

u/l

0.71

395

Viral infections characterized by skin and mucous membrane lesions, including avohilmo

1020

6258

1.27

11.83

1.2

1.3

42.22

31.16

u/l

1.59

902

5459

Pregnancy hypertension

305

1763

1.55

11.82

1.2

28.83

26.98

u/l

0.12

272

1540

Coxibs

334

1133

1.56

11.78

1.2

1.3

38.68

38.36

u/l

0.01

290

981

Other neurological diseases

868

5204

1.30

11.77

1.2

1.3

35.30

33.59

u/l

0.16

768

4510

Disorders of adult personality and behaviour

281

1795

1.58

11.75

1.2

1.3

30.64

28.62

u/l

0.11

248

1578

Other external causes of accidental injury

892

3434

1.31

11.74

1.4

1.2

34.88

30.83

u/l

0.38

782

2989

Hypokalaemia

154

839

1.86

11.70

1.3

29.72

43.62

u/l

1.18

130

715

Pruritus

142

754

1.91

11.68

1.2

50.99

30.18

u/l

0.56

122

644

Acute upper respiratory infections

1185

5679

1.25

11.67

1.3

38.77

32.04

u/l

0.78

1041

4939

Noninfective enteritis and colitis

517

3724

1.39

11.64

1.2

1.3

44.42

30.19

u/l

0.93

463

3231

Other diseases of anus and rectum

362

2438

1.49

11.63

1.3

32.61

33.03

u/l

0.02

313

2089

Disturbance of activity and attention

104

482

2.12

11.60

1.2

1.3

11.36

26.84

u/l

1.51

426

Personality disorders

269

1708

1.59

11.56

1.2

1.3

30.42

27.74

u/l

0.15

237

1497

COPD, hospital admissions

593

3677

1.37

11.54

1.3

29.20

36.71

u/l

1.40

507

3171

Disorders of lacrimal system

493

3475

1.40

11.52

1.4

1.3

30.65

35.74

u/l

0.50

422

3001

Systemic connective tissue disorders

399

2756

1.46

11.50

1.2

1.3

35.72

35.00

u/l

0.04

359

2371

Other noninfective gastroenteritis and colitis

288

1859

1.56

11.50

1.3

51.87

34.60

u/l

0.66

260

1612

Myalgia

255

1603

1.60

11.44

1.2

23.09

34.81

u/l

2.06

220

1379

Mycoses

337

2255

1.51

11.43

1.3

42.98

30.32

u/l

1.32

293

1955

Rotator cuff syndrome

723

3761

1.33

11.42

1.3

34.34

33.45

u/l

0.05

647

3258

COPD, early/later onset

598

3705

1.36

11.42

1.3

30.02

36.59

u/l

1.10

513

3195

Acute posthaemorrhagic anaemia

187

2.90

11.41

1.4

1.3

46.80

26.20

u/l

0.95

161

Other/unspecified dorsalgia

412

2834

1.44

11.31

1.3

30.10

31.53

u/l

0.12

372

2425

Other diseases of lip and oral mucosa

474

3393

1.41

11.21

1.3

39.06

33.16

u/l

0.29

415

2941

Hyperplasia of prostate

511

2057

1.41

11.16

1.3

35.82

32.90

u/l

0.17

455

1799

Other and unspecified coagulation defects

312

2.42

11.15

1.9

1.3

21.47

23.93

u/l

0.17

266

Secondary uncertain malignant neoplasm

154

852

1.83

11.14

1.5

1.2

102.97

19.23

u/l

2.58

136

725

Malignant neoplasm of kidney, except renal pelvis, including Hilmo

127

661

1.95

11.14

1.7

1.2

51.11

18.31

u/l

1.09

112

558

Spondylosis

645

3771

1.34

11.13

1.4

1.3

34.33

31.75

u/l

0.16

573

3257

Viral infections characterized by skin and mucous membrane lesions

482

3468

1.40

11.00

1.3

46.38

29.19

u/l

1.80

434

3005

Hyperkinetic disorders

108

518

2.05

10.99

1.2

1.3

11.16

31.72

u/l

2.03

459

Other arthrosis

617

3070

1.35

10.94

1.2

1.3

33.73

30.84

u/l

0.18

558

2663

Other viral diseases

301

1978

1.53

10.93

1.4

1.3

59.54

29.89

u/l

1.35

269

1746

Accidents

884

3434

1.29

10.92

1.3

1.2

35.00

30.83

u/l

0.39

774

2989

Any mental disorder

1233

4987

1.24

10.83

1.3

30.70

33.35

u/l

0.31

1075

4355

Other disorders of veins

454

3195

1.41

10.78

1.2

1.3

40.18

31.76

u/l

0.53

387

2759

Non-allergic asthma (mode)

203

1219

1.66

10.59

1.3

25.50

25.22

u/l

0.02

189

1041

Cirrhosis of liver, NAS

458

2.12

10.44

1.3

48.98

41.61

u/l

0.24

389

Other viral diseases, including avohilmo

370

2541

1.45

10.44

1.4

1.3

51.13

31.34

u/l

1.01

336

2231

Depression

1033

5523

1.25

10.43

1.2

1.3

28.05

32.11

u/l

0.64

914

4820

Non-follicular lymphoma

143

792

1.84

10.42

1.3

84.09

40.91

u/l

1.91

126

685

Lumbar disc prolapse

719

4083

1.31

10.38

1.3

34.80

32.18

u/l

0.16

641

3544

Dermatitis and eczema

1257

6076

1.23

10.28

1.3

37.39

31.32

u/l

0.68

1111

5296

Mycoses, including avohilmo

1025

6262

1.25

10.24

1.3

33.17

32.63

u/l

0.05

871

5499

Disorders of skin appendages

511

3745

1.36

10.14

1.2

1.3

33.77

31.37

u/l

0.13

463

3255

ILD medications: azathioprine

156

893

1.76

10.10

1.3

1.2

31.39

20.17

u/l

0.95

135

771

Fibrosis and cirrhosis of liver

114

594

1.95

10.06

1.2

1.3

44.17

39.75

u/l

0.16

105

510

Viral pneumonia (known virus, not influenza)

201

2.72

10.05

1.2

99.96

39.20

u/l

1.00

173

Paracetamol or NSAID medication

173

495

1.77

10.05

1.2

39.19

30.96

u/l

0.32

155

425

Acute upper respiratory infections of multiple and unspecified sites

823

4703

1.28

10.04

1.3

36.83

31.10

u/l

0.48

727

4082

Hypothyroidism, strict autoimmune, 3 medication purchases required

871

4610

1.27

10.04

1.3

27.88

34.45

u/l

1.34

759

3989

Insulin, fast-acting (human)

156

895

1.76

10.03

1.2

43.88

36.50

u/l

0.18

137

781

Myocarditis

206

2.66

10.02

1.2

1.3

45.19

33.07

u/l

0.18

183

Follow-up examination after treatment for conditions other than malignant neoplasms

405

1896

1.43

10.00

1.5

1.3

34.91

28.50

u/l

0.40

357

1616

All influenza (not pneumonia)

172

1015

1.71

10.00

1.4

1.3

77.07

22.86

u/l

1.84

150

880

Conductive and sensorineural hearing loss

927

4890

1.26

9.94

1.3

35.54

31.34

u/l

0.52

795

4268

Disorder of lipoprotein metabolism, unspecified

171

1015

1.70

9.78

1.2

1.3

24.20

38.56

u/l

1.53

160

866

Redundant prepuce, phimosis and paraphimosis

270

1757

1.52

9.77

1.3

19.84

31.69

u/l

2.85

242

1542

Acute pancreatitis

242

1565

1.56

9.73

1.2

1.3

30.40

33.59

u/l

0.16

211

1356

Other diseases of pancreas

118

629

1.91

9.73

1.2

37.79

40.71

u/l

0.06

105

548

Symptoms and signs involving the nervous and musculoskeletal systems

656

5044

1.31

9.71

1.2

1.3

25.11

34.61

u/l

2.73

577

4373

COPD-related respiratory insufficiency

172

1026

1.70

9.68

1.2

1.3

37.70

39.36

u/l

0.08

135

880

Irritable bowel syndrome

278

1855

1.51

9.63

1.2

1.3

24.80

32.52

u/l

0.94

248

1592

Anxiety disorders, excluding more controls

879

4448

1.27

9.63

1.3

29.73

31.68

u/l

0.18

766

3884

Disorders of synovium and tendon

570

3640

1.33

9.61

1.2

1.3

32.52

33.46

u/l

0.06

509

3159

Injuries to the shoulder and upper arm

988

6144

1.24

9.56

1.3

31.48

32.25

u/l

0.07

869

5354

Other pleural conditions

147

843

1.77

9.55

1.6

1.3

36.91

40.62

u/l

0.20

129

725

Injuries to the abdomen, lower back, lumbar spine and pelvis

472

3420

1.37

9.54

1.4

1.3

30.35

32.40

u/l

0.21

411

2949

Zoster [herpes zoster], including avohilmo

602

4430

1.32

9.46

1.2

1.3

49.03

32.50

u/l

1.65

524

3834

Malignant neoplasm of kidney, except renal pelvis

112

593

1.91

9.42

1.7

1.2

54.59

18.78

u/l

1.03

505

COPD, hospital admission 2, with asthma infections

418

2596

1.40

9.37

1.3

30.55

35.64

u/l

0.66

354

2234

Coronary artery bypass grafting

328

1675

1.46

9.32

1.2

1.4

34.78

41.97

u/l

0.60

291

1439

Sensorineural hearing loss

889

4728

1.26

9.27

1.3

31.23

31.78

u/l

0.06

760

4121

Amputation of ankle bones

153

2.90

9.24

1.2

21.77

41.53

u/l

0.97

130

Early onset COPD

279

1883

1.50

9.22

1.4

1.3

28.97

33.18

u/l

0.35

237

1621

Malignant neoplasm of bladder, including Hilmo

139

781

1.78

9.22

1.2

34.69

18.92

u/l

1.07

122

666

Osteonecrosis due to drugs

111

3.30

9.21

1.4

1.2

59.79

22.55

u/l

1.38

Other extrapyramidal and movement disorders in other diseases

296

2023

1.47

9.17

1.2

1.3

33.51

34.30

u/l

0.03

247

1746

Mental and behavioural disorders due to opioids

187

2.67

9.15

1.1

1.2

88.81

35.09

u/l

0.50

164

Malignant neoplasm of urinary organs

119

649

1.86

9.14

1.6

1.2

54.06

18.61

u/l

1.12

106

548

Substance use, excluding alcohol

225

1453

1.56

9.13

1.2

1.3

52.41

28.25

u/l

0.82

180

1276

Any death

770

4238

1.28

9.12

1.5

1.3

69.39

26.26

u/l

8.04

676

3679

Bipolar affective disorders

182

1118

1.64

9.10

1.2

1.3

32.96

30.70

u/l

0.09

152

973

Traumatic subdural haemorrhage

184

1059

1.64

9.08

1.3

52.42

37.65

u/l

0.53

158

908

Other reaction to severe stress, and adjustment disorders

337

2361

1.43

9.05

1.3

1.2

33.11

29.10

u/l

0.26

300

2090

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

156

799

1.71

9.01

1.2

1.3

25.96

32.98

u/l

0.19

134

701

Charcot foot

102

3.35

9.00

1.1

1.4

18.23

44.38

u/l

0.84

Soft tissue disorders related to use, overuse and pressure

315

2186

1.45

9.00

1.2

1.3

23.26

35.58

u/l

2.45

284

1885

Vasculitis limited to skin, not elsewhere classified

178

2.72

8.98

1.1

1.2

71.67

39.30

u/l

0.46

156

Disturbances of skin sensation

285

1943

1.48

8.93

1.3

1.2

22.50

29.97

u/l

0.96

254

1680

Menorrhagia

278

1031

1.51

8.88

1.4

1.2

27.66

33.86

u/l

0.62

227

888

Cholecystitis

173

1057

1.65

8.88

1.2

1.3

56.22

41.38

u/l

0.27

148

919

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

111

598

1.88

8.87

1.6

1.2

42.61

32.62

u/l

0.44

526

Subjective visual disturbances

285

1948

1.47

8.83

1.2

1.3

27.19

32.00

u/l

0.50

251

1685

Sciatica+with lumbago

564

3807

1.32

8.81

1.4

1.3

32.50

31.45

u/l

0.07

512

3300

In situ neoplasms

445

3290

1.36

8.76

1.2

1.3

40.53

33.35

u/l

0.59

395

2830

Unspecified acute lower respiratory infection

189

1188

1.61

8.66

1.2

39.80

32.63

u/l

0.39

172

1037

Other embolism and thrombosis

158

951

1.68

8.63

1.6

1.3

60.11

37.25

u/l

0.60

140

817

Heart failure and hypertrophic cardiomyopathy

137

2.96

8.62

1.3

1.2

54.31

38.71

u/l

0.17

117

Mixed hyperlipidaemia

286

2.29

8.57

1.2

1.3

20.67

45.47

u/l

1.31

245

Chronic rhinitis, nasopharyngitis and pharyngitis

333

2359

1.42

8.49

1.2

1.3

26.78

28.24

u/l

0.14

303

2038

Acetic acid derivatives and related substances

316

1123

1.46

8.48

1.3

28.68

38.63

u/l

0.85

272

972

146

865

1.70

8.44

1.5

1.2

42.24

24.70

u/l

1.27

136

741

Status post-ami

328

1750

1.43

8.42

1.2

1.4

34.94

41.43

u/l

0.57

291

1506

Transient ischemic attack

627

3881

1.29

8.41

1.2

1.3

35.40

35.90

u/l

0.03

551

3353

Paroxysmal nocturnal haemoglobinuria [Marchiafava-Micheli]

28.68

8.41

1.6

1.0

109.56

21.17

u/l

—

External causes of morbidity and mortality

675

2627

1.29

8.39

1.2

40.60

28.18

u/l

1.13

585

2289

Umbilical hernia

331

2350

1.42

8.39

1.3

33.42

30.00

u/l

0.20

294

2045

Renal tubulo-interstitial disorders in diseases classified elsewhere

4.01

8.38

1.2

1.1

15.14

44.08

u/l

0.84

Meniscus derangement

617

3165

1.30

8.37

1.2

1.3

24.35

30.80

u/l

1.00

519

2750

Problems related to lifestyle

124

706

1.77

8.29

1.2

1.3

27.99

26.66

u/l

0.07

110

613

Specific personality disorders

218

1430

1.53

8.27

1.2

1.3

30.93

27.92

u/l

0.15

195

1255

Urinary track infection

456

1680

1.36

8.27

1.3

1.2

31.32

32.86

u/l

0.08

395

1442

Zoster [herpes zoster]

225

1492

1.52

8.16

1.3

56.52

38.14

u/l

0.92

197

1292

Impotence

496

1.93

8.11

1.2

1.3

24.69

41.08

u/l

0.90

428

Use of anticholinesterases

239

2708

0.68

8.09

1.3

35.78

37.35

u/l

0.09

198

2320

N06DA Anticholinesterases

239

2708

0.68

8.09

1.3

35.78

37.35

u/l

0.09

198

2320

Azathioprine

156

953

1.65

8.05

1.3

1.2

31.39

31.80

u/l

0.02

135

824

Polyarthrosis

229

1374

1.51

7.98

1.3

40.68

38.10

u/l

0.06

199

1178

Other and unspecified drugs and medicaments

104

569

1.85

7.98

1.6

1.2

44.99

39.48

u/l

0.18

486

Excessive, frequent and irregular menstruation

292

1070

1.46

7.97

1.3

1.2

24.77

35.81

u/l

1.36

242

924

ILD, hospital admission 2, with pulmonary infections

126

730

1.75

7.97

1.3

52.74

28.32

u/l

0.74

112

617

Hypocalcemia

166

2.67

7.96

1.3

1.2

27.21

26.45

u/l

0.03

145

Benign neoplasm: Transverse colon

152

928

1.66

7.93

1.5

1.3

59.44

39.27

u/l

0.57

133

803

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

199

1295

1.55

7.92

1.3

43.03

34.94

u/l

0.54

181

1121

Restless leg syndrome

167

1043

1.62

7.92

1.2

1.3

34.32

35.39

u/l

0.03

142

910

malignant neoplasm of male genital organs, including Hilmo

349

1498

1.41

7.89

1.9

1.2

43.68

18.61

u/l

2.17

296

1287

Benign neoplasm of other and ill-defined parts of digestive system

213

1407

1.53

7.89

1.4

1.3

34.65

36.72

u/l

0.11

193

1210

Rheumatism, unspecified

137

814

1.70

7.88

1.2

31.99

33.17

u/l

0.05

115

701

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

327

2024

1.41

7.84

1.2

27.92

28.35

u/l

0.03

290

1757

COPD, hospital admissions 3, with asthma pneumonia sepsis

348

2156

1.39

7.80

1.3

30.98

36.62

u/l

0.77

293

1856

Persistent mood disorders

205

1347

1.53

7.77

1.2

1.3

24.16

32.82

u/l

0.89

177

1168

820

0.36

7.76

1.2

1.3

30.20

41.90

u/l

0.42

713

Oter anti-inflammatory and antirheumatic agents, non-steroids

270

1011

1.48

7.75

1.3

37.31

38.32

u/l

0.04

239

873

Other skin changes

242

1649

1.48

7.71

1.4

1.3

72.78

35.88

u/l

1.66

216

1415

Other diseases of pericardium

286

2.21

7.71

1.2

1.3

34.61

28.39

u/l

0.21

239

Diabetic retinopathy, excluding more controls

405

1667

1.37

7.66

1.2

35.94

26.58

u/l

0.91

352

1420

Migraine without aura

145

880

1.66

7.66

1.2

16.62

30.30

u/l

2.33

131

759

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

240

1613

1.48

7.62

1.3

1.2

22.56

31.07

u/l

0.66

200

1426

Other gastritis (incl. Duodenitis)

258

1786

1.46

7.57

1.5

1.3

45.07

34.17

u/l

0.67

234

1525

Use of pramipexole

257

1782

1.45

7.49

1.2

1.3

27.90

36.77

u/l

0.98

212

1548

Candidiasis

155

965

1.62

7.46

1.3

1.2

39.49

34.94

u/l

0.20

133

833

Recurrent or chronic depression

391

2002

1.36

7.44

1.2

1.3

21.30

28.61

u/l

0.90

338

1766

Anxiety (asthma-related co-morbidities)

567

3359

1.29

7.42

1.2

1.3

24.98

30.78

u/l

0.52

498

2947

Coxarthrosis, primary

717

4785

1.25

7.36

1.3

40.81

33.99

u/l

0.56

617

4136

Other disorders of adrenal gland

272

2.21

7.36

1.3

30.80

32.17

u/l

0.04

233

Other disorders of bone

208

1389

1.51

7.34

1.2

1.3

26.13

31.60

u/l

0.44

174

1206

Neurotic, stress-related and somatoform disorders

910

5156

1.22

7.27

1.3

31.37

30.97

u/l

0.03

792

4510

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

124

736

1.71

7.24

1.4

1.2

86.83

37.68

u/l

1.24

109

641

Undetermined asthma, excluding more controls

130

780

1.68

7.21

1.6

1.3

56.46

26.67

u/l

0.63

119

666

Cardiac arrest

280

2.08

7.20

1.3

1.5

33.62

28.95

u/l

0.17

234

Abnormal results of function studies

109

625

1.76

7.20

1.4

1.3

43.47

38.83

u/l

0.08

536

Anxiety disorders

920

5204

1.22

7.18

1.3

31.21

30.85

u/l

0.03

801

4556

Abnormal findings on diagnostic imaging of other body structures

168

1078

1.57

7.15

1.3

35.92

36.11

u/l

0.01

150

929

Other systemic involvement of connective tissue

296

2123

1.40

7.15

1.2

1.3

34.25

34.58

u/l

0.02

262

1833

Abnormal weight loss

122

724

1.71

7.14

1.6

1.2

25.84

38.65

u/l

1.08

113

627

Malignant neoplasm of prostate, including Hilmo

338

1444

1.39

7.12

2.0

1.2

44.92

18.73

u/l

2.19

285

1237

Non-Hodgkin lymphoma, all

264

2.20

7.05

1.3

1.2

57.53

21.18

u/l

1.39

225

Injury, poisoning and certain other consequences of external causes

545

2115

1.30

7.04

1.3

1.2

37.82

30.06

u/l

0.58

469

1826

Acute pancreatitis (for exclusion)

242

1681

1.45

7.03

1.2

1.3

30.40

34.71

u/l

0.23

211

1456

Other and unspecified vasculitis limited to skin

165

2.55

7.01

1.1

1.2

80.96

38.56

u/l

0.53

144

Irregular menses

338

1853

1.37

7.00

1.2

22.96

30.15

u/l

0.62

290

1623

Benign neoplasm of other and unspecified endocrine glands

160

1021

1.58

7.00

1.2

1.3

24.39

40.00

u/l

1.67

146

889

Other diseases of intestine

187

1235

1.53

6.99

1.2

1.3

30.00

33.82

u/l

0.24

170

1060

Intracranial injury

646

4823

1.25

6.95

1.3

36.04

34.21

u/l

0.12

567

4190

Functional dyspepsia

276

1966

1.41

6.95

1.4

1.2

36.91

32.00

u/l

0.21

245

1695

Arthropathies in other diseases classified elsewhere

221

2.31

6.93

1.2

1.3

27.92

30.40

u/l

0.07

187

Other epidermal thickening

307

2.09

6.86

1.2

1.3

30.77

34.46

u/l

0.10

261

Weight loss

128

778

1.66

6.85

1.6

1.2

25.52

37.22

u/l

1.03

119

672

Benign neoplasm: Rectum, anus and anal canal

250

1760

1.43

6.78

1.3

42.02

34.53

u/l

0.34

217

1518

Acidosis

150

2.61

6.77

1.6

1.4

23.36

35.77

u/l

0.70

129

Fissure and fistula of anal and rectal regions

261

1853

1.42

6.72

1.3

23.78

31.48

u/l

1.22

230

1604

Falls/tendency to fall

1130

4767

1.19

6.71

1.3

34.37

30.17

u/l

0.47

990

4161

Substance abuse, excluding more controls

606

4042

1.26

6.67

1.2

1.3

36.43

31.57

u/l

0.33

508

3545

Superficial injury of lower leg

272

1948

1.40

6.66

1.4

1.3

33.25

33.27

u/l

0.00

243

1699

Generalized anxiety disorder

136

844

1.62

6.62

1.2

11.41

29.32

u/l

3.01

118

739

Other benign neoplasms of skin

409

3122

1.32

6.62

1.3

43.51

31.94

u/l

0.66

355

2693

Hypertrophic cardiomyopathy

312

2.06

6.60

1.2

1.3

49.84

38.45

u/l

0.19

262

Viral and other specified intestinal infections

185

1203

1.51

6.60

1.3

1.2

39.83

26.64

u/l

0.36

166

1054

Emphysema

102

591

1.75

6.55

1.3

1.2

30.41

42.15

u/l

0.77

507

Poisoning by drugs, medicaments and biological substances

222

1538

1.45

6.54

1.2

1.3

25.92

29.81

u/l

0.22

186

1351

Allergic asthma (mode), excluding more controls

186

1216

1.50

6.46

1.2

1.3

39.71

22.73

u/l

0.57

166

1048

Oxicams

266

1067

1.42

6.45

1.3

1.2

25.73

40.13

u/l

1.76

229

922

Benign neoplasm: Colon, unspecified

309

2275

1.37

6.44

1.3

44.23

34.30

u/l

0.58

261

1959

Sequelae of cerebrovascular disease

443

2928

1.30

6.37

1.3

29.66

37.05

u/l

1.12

382

2511

Retinal haemorrhage

173

2.43

6.36

1.2

70.04

43.76

u/l

0.47

152

Right bundle-branch block

236

2.20

6.36

1.1

1.3

29.37

28.82

u/l

0.02

196

Diseases of external ear

391

2985

1.32

6.34

1.6

1.3

27.16

32.15

u/l

0.43

325

2603

Unspecified fall

563

4413

1.26

6.33

1.2

1.3

40.98

32.39

u/l

0.50

484

3824

ILD, hospital admissions 3, with pneumonia sepsis

110

659

1.69

6.27

1.3

58.04

24.67

u/l

0.97

564

Exposure to other specified factors

842

6015

1.20

6.23

1.3

31.94

32.59

u/l

0.05

737

5265

Paralytic ileus and intestinal obstruction

285

2080

1.38

6.23

1.2

1.3

37.20

34.23

u/l

0.12

247

1776

malignant neoplasm of male genital organs

331

1473

1.36

6.23

2.0

1.2

45.13

18.74

u/l

2.16

280

1263

Vascular diseases of the intestine

278

2.09

6.23

1.2

93.62

41.94

u/l

0.61

242

Congenital malformations, deformations and chromosomal abnormalities

546

4127

1.26

6.19

1.3

38.80

28.86

u/l

0.68

486

3619

Other anxiety disorders

413

2703

1.30

6.18

1.2

27.89

30.54

u/l

0.14

361

2395

Clear cell adenocarcinoma of kidney

313

2.01

6.17

1.6

1.2

68.29

17.67

u/l

0.82

268

Other abnormal uterine and vaginal bleeding

194

943

1.49

6.16

1.3

1.2

29.80

32.36

u/l

0.19

165

808

Stomatitis and related lesions

205

1417

1.46

6.16

1.3

41.62

34.29

u/l

0.35

185

1232

Other respiratory diseases principally affecting the interstitium

223

1569

1.43

6.12

1.2

1.3

47.05

35.10

u/l

0.43

196

1343

Malignant neoplasm of prostate

324

1417

1.36

6.10

2.1

1.2

46.33

18.82

u/l

2.21

272

1212

All anxiety disorders

578

3597

1.25

6.08

1.2

24.69

29.44

u/l

0.42

508

3173

Benign neoplasm: Ascending colon

181

1227

1.49

6.06

1.6

1.3

42.76

36.44

u/l

0.20

157

1065

Hypoparathyroidism

228

2.19

6.06

1.3

1.2

21.59

21.20

u/l

0.02

192

Other infectious diseases, including avohilmo

111

673

1.67

6.06

1.3

1.2

98.93

40.67

u/l

1.52

576

Hodgkin lymphoma, hilmo

177

2.37

6.05

1.1

1.2

68.25

39.48

u/l

0.50

152

Abnormal blood-pressure reading, without diagnosis

254

2.11

6.05

1.4

1.2

19.58

40.45

u/l

1.00

210

Unspecified privation

126

789

1.61

6.04

1.2

32.26

40.03

u/l

0.25

113

689

Pleural effusion

193

1327

1.47

6.00

1.6

1.3

50.01

37.18

u/l

0.87

171

1147

Complications of internal orthopaedic prosthetic devices, implants and grafts

258

1868

1.39

5.99

1.4

1.2

42.12

33.15

u/l

0.30

224

1598

Internal derangement of knee

381

2892

1.31

5.99

1.2

1.3

19.84

30.18

u/l

3.60

330

2514

Arterial embolism and thrombosis

423

1.84

5.95

1.2

1.3

54.88

45.09

u/l

0.12

364

Degeneration of macula and posterior pole

570

3535

1.25

5.93

1.4

1.3

44.22

36.29

u/l

0.50

479

3050

Injuries to the thorax

540

4329

1.25

5.91

1.3

45.30

31.94

u/l

0.88

470

3762

Benign neoplasm: Rectum

223

1583

1.42

5.85

1.3

34.63

34.78

u/l

0.01

192

1364

Inflammatory diseases of female pelvic organs

481

2591

1.27

5.84

1.3

1.2

27.28

34.16

u/l

0.61

411

2261

Other disorders of penis

127

803

1.60

5.84

1.4

1.3

20.57

35.08

u/l

1.18

108

698

Chronic sinusitis

419

3263

1.29

5.81

1.4

1.3

30.32

31.20

u/l

0.07

379

2820

Pre-eclampsia or eclampsia

151

994

1.53

5.79

1.3

1.2

42.76

26.63

u/l

0.81

132

862

Alzheimer’s disease, strict definition

171

2015

0.68

5.79

1.3

33.27

38.87

u/l

0.41

146

1722

Use of memantine

193

2216

0.70

5.75

1.2

1.3

30.88

38.48

u/l

0.65

164

1898

Use of other anti-dementia drugs

193

2216

0.70

5.75

1.2

1.3

30.88

38.48

u/l

0.65

164

1898

Pre-eclampsia or poor fetal growth

193

1331

1.45

5.73

1.3

1.2

41.92

25.36

u/l

0.86

172

1167

Leiomyoma of uterus

497

2201

1.27

5.72

1.2

32.77

31.47

u/l

0.07

425

1914

Other and unspecified epidermal thickening

163

2.38

5.71

1.2

36.50

36.07

u/l

0.01

146

Fracture of rib(s), sternum and thoracic spine

370

2852

1.30

5.66

1.3

47.77

33.08

u/l

0.62

319

2466

Migraine with aura and triptan purchases

120

754

1.60

5.66

1.2

1.3

22.14

26.76

u/l

0.17

105

662

Benign neoplasm: Adrenal gland

595

1.69

5.63

1.3

1.2

27.66

33.99

u/l

0.33

515

Hyperaldosteronism

203

2.22

5.60

1.3

1.2

17.86

28.78

u/l

0.88

178

COPD, hospital admissions 1, only main diagnosis

414

2781

1.29

5.58

1.3

28.99

35.48

u/l

1.05

349

2396

Hypotension

218

1555

1.41

5.57

1.2

1.3

31.53

39.06

u/l

0.69

196

1328

Ascites

574

1.69

5.57

1.2

1.3

51.81

43.60

u/l

0.29

493

Benign neoplasm: Stomach

117

736

1.61

5.55

1.6

1.2

38.58

36.61

u/l

0.07

107

628

Other bursopathies

150

997

1.52

5.55

1.2

22.01

39.00

u/l

2.49

133

853

Other disorders of glucose regulation and pancreatic internal secretion

559

1.70

5.55

1.5

1.3

47.95

36.01

u/l

0.19

486

Other and unspecified types of non-Hodgkin lymphoma, hilmo

305

1.97

5.54

1.3

1.2

101.98

41.91

u/l

1.16

264

Myocardial infarction, with ST-elevation

220

1574

1.41

5.54

1.2

1.3

29.80

35.85

u/l

0.51

196

1346

Extrapyramidal and movement disorders

435

3435

1.27

5.51

1.2

1.3

31.16

34.29

u/l

0.19

364

2967

Fracture of lumbar spine and pelvis

260

1908

1.37

5.51

1.4

1.2

33.60

38.44

u/l

0.39

219

1637

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

544

4244

1.24

5.50

1.2

1.3

35.13

31.76

u/l

0.26

477

3695

Polyuria

265

1957

1.36

5.49

1.2

1.3

26.37

36.11

u/l

1.40

225

1707

Localized swelling, mass and lump of skin and subcutaneous tissue

340

2607

1.31

5.42

1.3

38.35

31.22

u/l

0.38

302

2253

Viral hepatitis, including avohilmo

481

1.74

5.39

1.3

41.81

32.60

u/l

0.24

412

Other CVD

244

1784

1.38

5.39

1.3

35.48

37.50

u/l

0.14

221

1526

Other complications of surgical and medical care, not elsewhere classified

106

656

1.63

5.38

1.2

47.92

32.32

u/l

0.71

569

Pre-eclampsia

138

907

1.53

5.37

1.4

1.2

43.52

25.58

u/l

0.85

121

788

Disorders of oesophagus in diseases classified elsewhere

137

2.47

5.35

1.2

55.83

23.02

u/l

0.68

114

Congenital malformations of the urinary system

358

1.87

5.35

1.2

1.3

38.28

32.98

u/l

0.12

311

Viral and other specified intestinal infections, including avohilmo

243

1708

1.37

5.34

1.3

38.54

28.30

u/l

0.34

214

1511

Cervical disc disorders

384

3000

1.29

5.32

1.3

21.99

32.18

u/l

2.88

333

2596

Emotionally unstable personality disorder

596

1.65

5.31

1.2

1.3

38.95

23.73

u/l

0.47

513

Acute generalized exanthematous pustulosis

282

1.98

5.29

1.3

1.2

50.66

29.34

u/l

0.49

245

Undetermined asthma

130

847

1.54

5.26

1.6

1.3

56.46

25.70

u/l

0.66

119

726

Thyrotoxicosis, other and/or unspecified

187

1312

1.43

5.26

1.3

1.2

27.81

33.55

u/l

0.30

173

1124

Mixed and other personality disorders

455

1.75

5.25

1.3

1.2

27.51

30.24

u/l

0.10

387

Degenerative diseases of the nervous system

278

2656

0.75

5.25

1.3

36.83

38.63

u/l

0.10

243

2270

Non-selective monoamine reuptake inhibitors

379

2839

1.29

5.24

1.2

1.3

26.06

33.45

u/l

1.12

321

2466

ILD-related respiratory insufficiency

256

2.03

5.24

1.2

1.3

69.59

46.19

u/l

0.23

220

Disorders of vitreous body

560

4351

1.23

5.21

1.3

44.26

33.55

u/l

0.91

490

3774

Anti-inflammatory and antirheumatic products, non-steroids

307

1156

1.34

5.20

1.3

39.44

37.70

u/l

0.07

266

1003

Abscess of anal and rectal regions

608

1.64

5.20

1.2

1.3

26.45

42.23

u/l

1.05

531

Gestational diabetes (for exclusion)

201

974

1.42

5.19

1.2

19.06

30.40

u/l

0.99

177

870

Other viral diseases, not elsewhere classified

179

1245

1.44

5.19

1.5

1.3

72.74

34.61

u/l

0.96

160

1098

Generalized skin eruption due to drugs and medicaments

230

2.07

5.15

1.3

1.2

55.57

27.67

u/l

0.58

201

Disorders of vitreous body and globe

573

4444

1.22

5.12

1.3

48.45

33.56

u/l

1.27

501

3852

Familial hypercholesterolemia

169

1171

1.45

5.12

1.2

1.4

33.65

39.09

u/l

0.33

150

1001

Viral warts

102

634

1.62

5.10

1.3

1.2

39.70

32.34

u/l

0.18

546

Malignant melanoma, including Hilmo

164

1130

1.46

5.10

1.2

71.90

18.46

u/l

1.93

147

973

Haemorrhoids and perianal venous thrombosis

362

2803

1.29

5.09

1.4

1.3

22.96

33.68

u/l

2.87

318

2407

Trochanteric bursitis

147

992

1.49

5.09

1.2

24.55

40.21

u/l

1.61

136

851

Diagnoses used for exclusion with ILD

283

2137

1.33

5.08

1.3

33.91

35.42

u/l

0.07

246

1835

Congenital malformations of the urinary system, including avohilmo

380

1.81

5.03

1.2

1.3

37.48

35.28

u/l

0.05

329

Allergic asthma (mode)

186

1282

1.42

5.02

1.2

39.71

21.84

u/l

0.61

166

1110

Deforming dorsopathies

273

2053

1.34

5.02

1.6

1.2

31.72

31.38

u/l

0.02

241

1761

Gestational [pregnancy-induced] hypertension

156

1066

1.47

4.99

1.2

32.15

25.80

u/l

0.28

142

932

Thoracic aortic aneurysm

187

1328

1.42

4.98

1.4

29.83

35.82

u/l

0.50

161

1151

Budesonide

139

932

1.50

4.97

1.5

1.2

58.33

33.04

u/l

0.70

127

793

Collagenous colitis

103

647

1.61

4.96

1.3

1.2

36.75

35.50

u/l

0.03

555

Other symptoms and signs involving cognitive functions and awareness

536

3882

1.23

4.95

1.3

34.79

35.84

u/l

0.08

480

3348

Malignant neoplasm of lip, including Hilmo

3.57

4.94

2.9

1.2

28.62

19.50

u/l

0.36

Retinal vascular disorders

147

1000

1.48

4.92

1.3

45.69

41.30

u/l

0.17

126

870

Abnormalities of gait and mobility

148

1009

1.48

4.91

1.2

1.3

23.52

39.01

u/l

2.31

121

870

Carcinoma in situ of skin of other and unspecified parts of face

114

736

1.57

4.90

1.3

1.2

53.79

37.78

u/l

0.37

629

Donors of organs and tissues

2.77

4.90

1.2

1.3

28.83

23.59

u/l

0.31

Other enthesopathies

289

2200

1.32

4.89

1.2

1.3

36.42

33.30

u/l

0.09

260

1904

Other diseases of stomach and duodenum

443

1.74

4.89

1.1

1.3

86.91

32.62

u/l

0.59

378

Fibromyalgia

465

1.71

4.88

1.1

1.2

19.21

19.91

u/l

0.06

396

Artificial joint operation, meniscal resection

1024

5649

1.16

4.88

1.3

29.55

32.69

u/l

0.37

892

4917

Alzheimer disease

248

2365

0.75

4.86

1.3

38.10

38.79

u/l

0.03

216

2021

Tobacco use

363

1.81

4.85

1.1

1.3

35.24

32.73

u/l

0.08

306

Other viral hepatitis, including avohilmo

392

1.78

4.84

1.3

44.65

30.19

u/l

0.35

335

Other infectious diseases

574

1.64

4.83

1.2

1.3

107.91

40.83

u/l

1.47

491

Retinal vascular occlusion

145

988

1.48

4.83

1.3

46.18

41.55

u/l

0.17

124

860

Noninfectious colitis NAS

143

971

1.48

4.83

1.2

65.60

38.50

u/l

0.53

131

841

ILD, hospital admissions

186

1328

1.41

4.81

1.2

1.3

40.66

38.06

u/l

0.08

167

1140

Diseases of peritoneum

116

755

1.55

4.81

1.2

1.3

21.35

35.81

u/l

1.99

109

655

Aortic aneurysm

284

2122

1.32

4.80

1.4

28.93

38.07

u/l

1.24

238

1835

Crohn disease

129

859

1.51

4.79

1.3

39.96

35.54

u/l

0.10

118

744

Other interstitial pulmonary diseases

188

1346

1.41

4.79

1.2

1.3

40.35

36.67

u/l

0.11

169

1160

Cervicalgia

214

1564

1.38

4.79

1.4

1.2

23.88

32.63

u/l

1.42

187

1337

Other disorders starting during childhood or adolecense, excluding more controls

102

2.54

4.75

1.4

1.2

11.58

40.41

u/l

0.79

Hydronephrosis

118

774

1.54

4.71

1.6

1.2

46.51

36.25

u/l

0.21

103

658

Interstitial lung disease endpoints

188

1351

1.40

4.70

1.2

1.3

40.35

38.00

u/l

0.07

169

1160

Interstitial lung disease

188

1351

1.40

4.70

1.2

1.3

40.35

38.00

u/l

0.07

169

1160

Diplopia

145

994

1.47

4.69

1.3

35.02

39.17

u/l

0.09

125

862

Somatoform disorder

155

1076

1.45

4.67

1.3

1.2

41.30

31.58

u/l

0.26

129

931

Crohn's disease NAS

404

1.75

4.67

1.2

1.3

24.13

34.05

u/l

0.58

349

Benign neoplasm: Sigmoid colon

223

1649

1.36

4.67

1.2

1.3

29.30

34.33

u/l

0.48

202

1426

Persons encountering health services for specific procedures, not carried out

587

1.62

4.66

1.3

1.2

79.39

36.17

u/l

0.67

503

Amenorrhoea

239

1.98

4.64

1.2

56.81

19.47

u/l

0.48

207

Viral hepatitis

450

1.71

4.63

1.3

44.07

33.33

u/l

0.26

386

Propionic acid derivatives

302

1156

1.32

4.63

1.3

39.74

37.70

u/l

0.08

262

1003

Other peripheral vascular diseases

534

1.64

4.63

1.3

24.81

34.02

u/l

0.67

461

L02BA Anti-estrogens

1032

0.57

4.59

1.3

1.2

25.74

25.13

u/l

0.04

894

Cholangitis (primary sclerosing, PSC)

429

1.72

4.58

1.2

52.08

38.76

u/l

0.30

371

Diseases of inner ear

582

4630

1.21

4.57

1.2

1.3

29.36

35.34

u/l

0.79

513

4014

Alzheimer’s disease (Late onset)

163

1886

0.71

4.57

1.3

34.08

39.29

u/l

0.35

138

1605

Unintentional cut, puncture, perforation or haemorrhage during surgical and medical care

536

1.64

4.57

2.0

1.3

26.75

36.12

u/l

0.71

462

Injuries to the hip and thigh

546

4044

1.21

4.57

1.4

1.3

38.86

33.77

u/l

0.32

488

3481

Congenital malformations, deformations and chromosomal abnormalities, including avohilmo

598

4538

1.20

4.56

1.3

38.01

29.85

u/l

0.58

533

3978

Other follicular disorders

475

1.68

4.55

1.2

40.23

32.55

u/l

0.12

410

Drug-induced cataract

161

2.22

4.55

1.3

1.2

57.97

16.11

u/l

0.97

137

Disorders of vestibular function (Vertigo)

494

3943

1.22

4.53

1.2

1.3

29.41

35.67

u/l

0.73

441

3402

Fitting and adjustment of other devices

404

2854

1.25

4.48

1.4

1.2

39.15

31.00

u/l

0.37

342

2440

Unspecified misadventure during surgical and medical care

440

1.70

4.48

1.2

1.3

27.65

35.51

u/l

0.44

379

355

2411

1.27

4.47

1.3

40.42

38.45

u/l

0.15

289

2084

Open wound of head

614

4830

1.20

4.46

1.3

29.20

32.17

u/l

0.29

535

4200

Dysphagia

276

2119

1.31

4.46

1.3

42.72

35.43

u/l

0.22

244

1795

Polycystic kidney disease

169

2.17

4.45

1.3

1.2

35.38

22.63

u/l

0.30

147

Visual impairment including blindness (binocular or monocular)

464

1.68

4.42

1.2

1.3

37.22

35.67

u/l

0.05

402

Other viral diseases, not elsewhere classified, including avohilmo

238

1781

1.33

4.40

1.4

1.3

57.63

29.90

u/l

0.94

217

1561

Other disorders of the musculoskeletal system and connective tissue

165

1175

1.41

4.37

1.6

1.3

42.06

34.86

u/l

0.21

150

1021

Heartburn

117

780

1.51

4.36

1.2

1.3

19.30

37.66

u/l

2.25

102

666

Malignant neoplasm of endocrine gland, including Hilmo

420

1.70

4.36

1.3

1.2

17.66

21.87

u/l

0.52

362

Diabetes mellitus in pregnancy

170

763

1.42

4.35

1.2

1.3

22.76

32.07

u/l

0.50

152

686

Chronic laryngitis and laryngotracheitis

145

1010

1.45

4.34

1.3

26.67

32.58

u/l

0.43

119

861

Acute suppurative otitis media

202

1384

1.36

4.34

1.2

34.26

31.04

u/l

0.14

173

1210

Recurrent aphthous stomatitis , including avohilmo

144

1002

1.45

4.33

1.3

1.2

45.06

38.76

u/l

0.21

132

870

Open wound of forearm

109

718

1.53

4.32

1.3

1.2

41.09

43.58

u/l

0.04

626

Acute laryngitis and tracheitis

604

1.57

4.31

1.2

81.43

24.24

u/l

0.93

518

Use of donepezil

134

1834

0.69

4.31

1.3

31.72

38.64

u/l

0.44

107

1563

Ovarian cyst

245

1050

1.34

4.31

1.3

1.2

35.13

33.17

u/l

0.06

221

907

Varicose veins

631

4007

1.19

4.29

1.3

39.12

32.39

u/l

0.48

559

3460

Other symptoms and signs involving the circulatory and respiratory systems

415

1.70

4.27

1.2

1.3

19.14

47.04

u/l

2.01

353

Cerebral cysts

363

1.75

4.27

1.4

1.3

41.50

33.67

u/l

0.21

307

Thyroiditis, ILD-related definition

104

680

1.54

4.25

1.3

1.2

29.92

33.38

u/l

0.17

585

Intestinal adhesions without obstruction

625

1.57

4.25

1.3

36.48

41.08

u/l

0.12

535

Hepatic failure, not elsewhere classified

262

1.90

4.25

1.6

1.3

73.70

38.30

u/l

0.62

220

Injuries to the knee and lower leg

1250

5962

1.13

4.23

1.3

25.90

34.09

u/l

1.77

1076

5221

Diseases of salivary glands

322

2542

1.27

4.21

1.2

1.3

24.68

32.16

u/l

1.07

274

2208

Otitis externa

230

1738

1.33

4.19

1.4

1.3

18.65

32.23

u/l

3.63

193

1515

Arterial embolism and thrombosis of lower extremity artery

249

1.92

4.19

1.2

1.3

27.94

41.55

u/l

0.66

218

Acute appendicitis

690

5449

1.18

4.18

1.2

1.3

37.57

30.48

u/l

0.51

611

4759

Primary gonarthrosis, bilateral

580

4070

1.20

4.17

1.3

34.11

34.40

u/l

0.02

505

3517

Urticaria and erythema

326

2580

1.27

4.16

1.3

1.2

26.89

31.60

u/l

0.28

284

2241

Acute gastritis

511

1.62

4.15

1.3

1.2

75.46

31.96

u/l

0.49

434

Mental and behavioural disorders due to use of other stimulants, including caffeine

128

2.30

4.15

1.2

1.3

16.86

30.20

u/l

0.34

115

severe traumatic brain injury, does not include concussion

256

1969

1.31

4.12

1.3

44.30

36.84

u/l

0.32

218

1696

Bronchitis, not specified as acute or chronic

598

1.57

4.12

1.2

1.3

64.88

31.83

u/l

0.67

514

Carcinoma in situ of skin of trunk

258

1.89

4.12

1.4

1.2

25.41

43.03

u/l

1.16

224

Suppurative and unspecified otitis media

299

2072

1.28

4.12

1.2

1.3

38.38

31.27

u/l

0.32

260

1810

Other and unspecified disorders of skin and subcutaneous tissue

405

1.70

4.11

1.3

1.2

33.13

32.25

u/l

0.03

346

Malignant melanoma

144

1013

1.43

4.10

1.2

78.45

19.03

u/l

1.86

129

868

Retinal detachments and breaks

396

3214

1.24

4.08

1.2

1.3

38.34

33.58

u/l

0.32

342

2775

Other hearing loss

319

2446

1.27

4.07

1.2

1.3

49.44

34.82

u/l

0.62

281

2102

Other specified/unspecified soft tissue disorders

302

1.81

4.06

1.2

31.18

33.84

u/l

0.10

257

Decubitus ulcer and pressure area

453

1.65

4.04

1.2

1.3

53.59

43.26

u/l

0.24

388

Malignant neoplasm of endocrine gland

362

1.73

4.02

1.3

1.2

17.70

20.48

u/l

0.30

310

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

240

1836

1.31

4.02

1.3

22.56

28.80

u/l

0.46

200

1612

Benign neoplasm: Caecum

131

911

1.45

4.01

1.3

27.54

39.68

u/l

1.15

121

782

Kela-code for severe mental illness

342

2737

1.25

4.00

1.2

1.3

25.69

29.76

u/l

0.36

297

2399

Dermatitis due to substances taken internally

341

1.75

3.98

1.3

49.58

38.06

u/l

0.22

287

Other retinal artery occlusion

164

2.11

3.96

1.1

1.2

65.65

55.23

u/l

0.16

142

KRA_PSY_EATING, excluding more controls

216

1.93

3.94

1.2

31.08

28.75

u/l

0.04

184

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly, including avohilmo

164

1154

1.39

3.94

1.2

1.3

35.54

33.94

u/l

0.07

145

1006

Unspecified mental disorder

372

3010

1.24

3.93

1.2

1.3

29.67

29.57

u/l

0.01

326

2626

Amyloidosis

158

2.13

3.92

1.4

1.2

28.92

41.53

u/l

0.46

133

Viral warts, including avohilmo

205

1541

1.34

3.91

1.3

48.78

29.89

u/l

0.68

186

1337

Encephalopathy

2.76

3.88

1.1

1.2

61.32

27.60

u/l

0.64

Benign thyroid growths and nodules

300

2203

1.27

3.88

1.3

1.2

40.92

38.13

u/l

0.09

261

1877

Disorders of sclera, cornea, iris and ciliary body

560

4723

1.19

3.88

1.4

1.3

37.08

31.91

u/l

0.44

499

4099

Other or unspecified ileus, impaction or obstruction

199

1491

1.34

3.88

1.2

1.3

37.93

33.35

u/l

0.15

171

1269

Conjunctivitis (acute, non atopic)

265

2056

1.29

3.87

1.2

1.3

28.89

30.02

u/l

0.06

227

1801

Papulosquamous disorders

407

3332

1.23

3.87

1.2

1.3

29.09

30.72

u/l

0.13

357

2899

Other and unspecified mood [affective] disorders

337

1.73

3.84

1.2

1.3

16.65

26.47

u/l

0.66

292

ILD, hospital admissions 1, main diag only

162

1180

1.38

3.82

1.2

1.3

44.50

39.03

u/l

0.15

143

1017

Sarcoidosis

138

978

1.42

3.82

1.2

1.3

24.91

40.11

u/l

1.29

125

848

Alzheimer disease, including avohilmo

299

2603

0.79

3.80

1.3

35.18

38.33

u/l

0.21

262

2220

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

140

996

1.41

3.77

1.2

1.3

28.39

30.51

u/l

0.07

113

868

Polycystic ovarian syndrome, broad definition

346

1.71

3.77

1.4

1.3

11.03

21.36

u/l

1.63

302

Schizophrenia or delusion, excluding more controls

270

2090

1.28

3.77

1.2

1.3

25.23

29.64

u/l

0.30

230

1819

Coxarthrosis, primary, with hip surgery

528

4118

1.19

3.76

1.3

47.96

35.78

u/l

0.83

447

3550

Aortic valve malfunction, age under 60 years

106

718

1.49

3.74

1.3

23.11

37.82

u/l

1.16

619

Other or ill-defined heart diseases

325

1.74

3.74

1.2

1.3

13.90

34.57

u/l

1.66

269

Cardiomyopathy, Hypertrophic obstructive

109

2.34

3.72

1.2

1.5

16.92

30.50

u/l

0.58

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

152

1066

1.39

3.71

1.2

1.3

37.03

33.69

u/l

0.14

134

930

Cervicocranial syndrome

108

736

1.48

3.69

1.3

1.2

39.79

31.88

u/l

0.23

628

Viral infections of the central nervous system

457

1.61

3.67

1.2

1.3

59.93

32.23

u/l

0.48

387

Polymyalgia rheumatica

154

1121

1.38

3.66

1.2

1.3

31.94

39.39

u/l

0.58

139

970

Unspecified dementia

856

0.60

3.63

1.2

39.11

42.61

u/l

0.10

730

Necrosis of pulp, including avohilmo

564

4730

1.18

3.63

1.4

1.3

29.08

28.37

u/l

0.06

486

4149

Other shoulder lesions

633

1.51

3.63

1.2

37.14

39.45

u/l

0.07

550

Non-allergic asthma

577

1.54

3.61

1.2

25.98

36.19

u/l

0.58

499

Speech and linguistic disorders, excluding more controls

328

1.70

3.61

1.2

1.3

24.75

30.58

u/l

0.29

291

Other viral hepatitis

374

1.67

3.61

1.3

47.77

29.93

u/l

0.40

321

Appendicitis, broad definition

732

5686

1.16

3.60

1.2

1.3

37.15

30.69

u/l

0.49

649

4970

Livedoid vasculitis

4.49

3.59

1.4

1.1

22.53

18.81

u/l

0.23

Phobic anxiety disorders

101

681

1.49

3.58

1.2

38.85

22.29

u/l

0.59

594

Colonic or urogenital fistula

273

2161

1.27

3.57

1.3

23.65

31.70

u/l

1.49

241

1881

Unspecific neurodegenerative disorder

354

2970

0.81

3.56

1.3

36.48

41.97

u/l

0.42

305

2547

Left ventricular outflow tract obstruction (LVOTO), broad definition

111

767

1.46

3.56

1.3

23.17

38.06

u/l

1.24

664

Panic disorder

113

783

1.45

3.54

1.2

16.99

29.59

u/l

1.41

686

Diabetic retinopathy, strict definition

243

1684

1.29

3.54

1.2

34.34

26.06

u/l

0.35

210

1479

Ganglion

183

1376

1.34

3.52

1.2

1.3

29.68

34.72

u/l

0.31

160

1185

Kela reimbursement Agammaglobulinemia (D80-84)

2.97

3.51

1.5

1.3

224.77

13.79

u/l

0.59

Lesion of ulnar nerve

153

1123

1.37

3.47

1.3

29.64

35.39

u/l

0.38

139

976

Embolic stroke with flimmer

166

2.02

3.46

1.2

30.04

42.20

u/l

0.35

140

Acute appendicitis, no complications

523

4405

1.18

3.46

1.2

1.3

33.02

27.85

u/l

0.40

466

3854

Seborrhoeic dermatitis

116

813

1.44

3.46

1.3

30.04

30.64

u/l

0.02

106

698

Mental and behavioural disorders due to psychoactive substance use

629

4951

1.17

3.46

1.2

1.3

35.97

30.49

u/l

0.40

528

4342

Any dementia

327

2783

0.81

3.45

1.3

40.64

39.19

u/l

0.06

289

2380

Smoking dependency

641

1.49

3.45

1.2

64.79

38.73

u/l

0.44

552

Crohn's disease of small intestine

418

1.62

3.44

1.2

1.3

54.05

36.86

u/l

0.22

358

Disorders of psychological development

540

1.52

3.44

1.2

1.3

66.89

34.94

u/l

0.42

470

Injuries to the wrist and hand

1041

6124

1.13

3.42

1.2

1.3

32.18

32.85

u/l

0.05

907

5356

Diseases of appendix

736

5723

1.15

3.42

1.2

1.3

37.51

30.72

u/l

0.52

653

5003

Pilonidal cyst

553

1.53

3.42

1.2

1.3

21.53

32.01

u/l

0.63

477

Periapical abscess

476

4010

1.19

3.40

1.4

1.3

32.63

28.40

u/l

0.22

418

3506

Enthesopathies of lower limb, excluding foot

217

1681

1.30

3.39

1.3

17.01

29.02

u/l

2.42

186

1453

Other inflammation of eyelid, including avohilmo

397

3291

1.21

3.38

1.4

1.3

24.60

32.87

u/l

0.91

346

2878

Other symptoms and signs involving the nervous and musculoskeletal systems

405

3365

1.21

3.37

1.2

1.3

22.18

32.99

u/l

2.84

370

2912

Urticaria

255

2017

1.27

3.36

1.3

23.82

30.82

u/l

0.36

221

1759

Open wound of lower leg

157

1164

1.36

3.35

1.2

1.3

54.82

38.58

u/l

0.37

133

1007

Medicines for HER+ breast cancer

196

2368

0.77

3.34

1.2

26.21

34.31

u/l

0.95

163

2052

Disorders of conjunctiva

812

5513

1.14

3.33

1.3

30.64

32.20

u/l

0.16

694

4825

Malignant neoplasm of thyroid gland

329

1.68

3.33

1.3

1.2

15.04

18.72

u/l

0.52

280

Mental and behavioural disorders due to tobacco

646

1.48

3.33

1.2

64.79

38.49

u/l

0.44

558

Calculus of kidney and ureter

328

2674

1.23

3.33

1.3

46.75

32.67

u/l

0.59

283

2314

Pneumonia due to Streptococcus pneumoniae

262

1.78

3.33

1.3

129.24

24.21

u/l

1.12

225

Vitamin B12 deficiency anaemia

108

753

1.44

3.32

1.3

1.2

110.98

31.64

u/l

1.49

644

Malignant neoplasm of thyroid gland, including Hilmo

368

1.64

3.31

1.3

1.2

15.62

18.77

u/l

0.45

313

Other inflammation of eyelid

147

1082

1.37

3.30

1.5

1.2

36.42

37.82

u/l

0.04

130

939

Uterine polyps

215

966

1.30

3.28

1.2

26.39

32.25

u/l

0.40

188

829

Other disorders of eyelid

476

3794

1.19

3.28

1.3

30.62

38.71

u/l

1.22

407

3283

Suicide or other Intentional self-harm

215

1672

1.29

3.27

1.2

1.3

24.10

29.22

u/l

0.31

177

1468

Inflammatory bowel disease

302

2445

1.24

3.27

1.2

1.3

32.78

30.33

u/l

0.11

267

2126

Other and unspecified nerve root and plexus disorders, also in other diseases

211

1638

1.29

3.27

1.5

1.2

26.24

31.14

u/l

0.40

183

1418

Any dementia, excluding more controls

302

2556

0.81

3.27

1.2

1.3

41.62

40.56

u/l

0.04

266

2178

Cardiac murmurs and other cardiac sounds

473

1.55

3.26

1.3

65.02

35.25

u/l

0.86

403

Paralytic strabismus

544

1.52

3.26

1.4

1.3

55.75

36.52

u/l

0.29

468

Appendectomy

604

4954

1.16

3.24

1.2

1.3

33.39

30.43

u/l

0.21

536

4328

Migraine without aura and triptan purchases

108

756

1.43

3.24

1.2

1.3

13.89

26.06

u/l

2.30

659

Polyp of the female genital tract

225

987

1.29

3.24

1.2

38.80

32.30

u/l

0.18

194

846

Maternal care for other conditions predominantly related to pregnancy

113

777

1.42

3.23

1.3

27.84

29.12

u/l

0.05

103

685

Wet age-related macular degeneration

199

1480

1.30

3.22

1.2

1.3

44.28

39.67

u/l

0.25

165

1266

Open wound of ankle and foot

108

758

1.43

3.22

1.2

1.3

24.77

37.84

u/l

0.85

658

Urolithiasis

354

2920

1.22

3.21

1.3

44.60

32.42

u/l

0.53

304

2532

Other specified and unspecified personality disorders

521

1.53

3.21

1.2

37.28

35.55

u/l

0.05

445

Orchitis and epididymitis

111

784

1.43

3.20

1.7

1.3

39.30

35.56

u/l

0.07

675

Conjunctivitis

707

4959

1.15

3.19

1.3

26.41

32.41

u/l

1.05

601

4341

Superficial injury of abdomen, lower back and pelvis

152

1131

1.35

3.19

1.4

1.3

27.12

38.03

u/l

0.83

136

985

Otalgia

506

1.53

3.18

1.4

1.2

32.93

33.93

u/l

0.02

439

Other and unspecified local infections of skin and subcutaneous tissue

103

719

1.44

3.17

1.2

1.3

32.58

39.79

u/l

0.32

621

Psoriasis

289

2339

1.24

3.16

1.3

29.79

29.80

u/l

0.00

259

2039

Colorectal cancer, including Hilmo

234

1721

1.27

3.15

1.2

55.94

20.48

u/l

1.52

204

1464

Post-traumatic stress disorder

358

1.63

3.13

1.8

1.2

14.41

28.31

u/l

1.14

309

Other and unspecified visual disturbances

105

738

1.43

3.12

1.3

1.2

25.15

42.09

u/l

1.22

635

Other diseases of oesophagus

101

705

1.44

3.11

1.3

1.2

40.88

36.59

u/l

0.17

603

Poisoning by medicine

182

1396

1.31

3.10

1.2

1.3

27.45

29.67

u/l

0.10

152

1228

Nonalcoholic steatohepatitis

2.75

3.10

1.2

1.3

13.87

14.72

u/l

0.06

Shock, not elsewhere classified

2.75

3.09

1.0

1.2

64.61

34.75

u/l

—

Other diseases of gallbladder

291

1.70

3.09

1.2

1.3

27.43

26.27

u/l

0.04

247

Malignant neoplasm of bladder

438

1.56

3.08

1.1

1.2

23.34

19.55

u/l

0.41

368

Undefined dementia

865

0.64

3.08

1.2

38.68

44.12

u/l

0.16

732

Other sleep disorders

109

773

1.42

3.08

1.2

24.64

37.39

u/l

1.06

670

Vasomotor and allergic rhinitis

312

2493

1.23

3.08

1.3

1.2

21.18

30.39

u/l

1.88

280

2167

Medial epicondylitis

239

1.78

3.07

1.2

1.3

14.52

26.34

u/l

1.28

205

Certain conditions originating in the perinatal period

250

1.71

3.07

2.0

1.2

35.78

16.37

u/l

0.58

216

Other local infections of skin and subcutaneous tissue

107

758

1.42

3.05

1.2

1.3

31.98

39.40

u/l

0.35

653

Asthma and allergy, excluding more controls

576

1.48

3.05

1.3

1.2

16.12

18.83

u/l

0.33

499

Superficial injury of head

249

1989

1.26

3.04

1.2

1.3

30.70

33.75

u/l

0.14

225

1704

Achilles tendinitis

108

767

1.42

3.04

1.4

1.3

20.61

30.66

u/l

0.75

658

Neuromuscular dysfunction of bladder

684

1.44

3.04

1.2

28.33

38.04

u/l

0.49

589

Antenatal screening

569

0.65

3.03

1.1

1.2

20.61

36.56

u/l

0.62

504

Open wound of wrist and hand

463

3801

1.18

3.02

1.2

1.3

33.14

28.29

u/l

0.30

402

3326

Substance abuse

606

4882

1.16

3.02

1.2

1.3

36.43

30.34

u/l

0.44

508

4277

Pain in thoracic spine

141

1047

1.35

3.02

1.3

30.81

30.34

u/l

0.02

131

898

Other/unspecified synovitis and tenosynovitis

108

768

1.41

3.01

1.2

1.3

45.05

41.69

u/l

0.06

660

Covid-19 suspected case

180

1386

1.30

2.99

1.3

35.52

29.28

u/l

0.24

161

1199

L02BG Aromatase inhibitors

161

2080

0.76

2.99

1.1

1.2

28.20

33.92

u/l

0.49

135

1804

Adhesive capsulitis of shoulder

166

1265

1.32

2.99

1.2

1.3

43.55

34.15

u/l

0.18

153

1084

Malignant melanoma of skin, including Hilmo

127

930

1.37

2.98

1.2

75.25

19.28

u/l

1.50

116

792

Other and unspecified nonorganic psychotic disorders

162

1231

1.32

2.97

1.3

1.2

27.95

32.26

u/l

0.17

138

1075

Hypoglycaemia, other or unspecified

443

1.55

2.96

1.6

1.3

61.05

37.76

u/l

0.29

384

Diabetic maculopathy

175

1271

1.31

2.95

1.2

22.74

24.89

u/l

0.13

155

1109

Mouth breathing

407

3426

1.19

2.95

1.3

25.45

28.85

u/l

0.54

362

2991

5-aminosalicylic acid

189

1468

1.29

2.95

1.2

26.80

28.91

u/l

0.14

170

1259

Moderate visual impairment, binocular

191

1.86

2.95

1.3

1.2

26.66

28.27

u/l

0.07

164

Peritonsillar abscess

180

1390

1.30

2.94

1.2

1.3

26.33

28.46

u/l

0.09

160

1208

Left bundle-branch block

492

1.52

2.93

1.2

1.3

30.38

31.47

u/l

0.04

412

Secondary sideroblastic anaemia

6.97

2.90

1.3

1.2

70.28

12.83

u/l

—

Monoamine oxidase A inhibitors

113

816

1.39

2.90

1.2

1.3

17.25

31.25

u/l

2.45

715

Mental and behavioural disorders due to sedatives or hypnotics

430

1.55

2.88

1.1

1.2

52.57

31.00

u/l

0.53

368

Myocardial infarction, unclassifiable

245

1758

1.25

2.87

1.3

38.53

38.41

u/l

0.01

210

1504

Presence of other devices

249

1975

1.25

2.86

1.3

29.05

33.89

u/l

0.54

217

1697

Cyst of kidney

586

1.46

2.85

1.1

1.3

21.79

36.18

u/l

1.46

512

Benign neoplasm: Skin of eyelid, including canthus

157

1197

1.32

2.84

1.3

44.87

37.00

u/l

0.21

138

1032

Presbycusis

155

1165

1.32

2.83

1.2

1.3

70.37

36.45

u/l

0.78

139

990

Endometriosis

227

1044

1.27

2.83

1.2

21.99

33.45

u/l

1.22

188

901

Duodenal ulcer

117

854

1.38

2.83

1.3

22.48

37.42

u/l

2.12

728

Rheumatoid arthritis

293

2127

1.22

2.82

1.3

65.44

34.08

u/l

1.27

270

1831

Nontoxic multinodular goitre

170

1312

1.30

2.81

1.3

1.2

31.79

37.81

u/l

0.37

147

1112

Frostbite

0.00

2.81

0.0

1.3

—

14.75

—

Other and unspecified tonsillitis

274

1855

1.23

2.79

1.2

1.3

31.92

27.03

u/l

0.13

237

1641

Abnormal involuntary movements

136

1020

1.34

2.77

1.3

35.75

37.31

u/l

0.06

116

888

Raynaud syndrome

548

1.47

2.76

1.2

24.27

29.11

u/l

0.31

471

Other and unspecified rosacea

581

1.46

2.76

1.3

23.76

27.09

u/l

0.26

500

Other female pelvic inflammatory diseases

120

883

1.37

2.76

1.3

1.2

17.61

25.29

u/l

1.66

101

764

Transport accidents

439

3114

1.18

2.75

1.3

1.2

22.51

30.63

u/l

1.61

391

2714

Other leukaemias of specified cell type

4.50

2.74

1.4

1.2

278.09

22.57

u/l

—

Diseases of middle ear and mastoid

510

3592

1.16

2.73

1.2

1.3

36.76

31.50

u/l

0.35

449

3134

Viral infections of the central nervous system, including avohilmo

501

1.49

2.72

1.2

1.3

59.17

30.72

u/l

0.51

425

Use of rivastigmine

100

1375

0.72

2.71

1.2

1.3

40.17

40.01

u/l

0.00

1160

Blepharochalasis

294

2428

1.22

2.71

1.2

1.3

29.30

38.57

u/l

1.18

245

2095

Dermatophytosis

149

1137

1.32

2.70

1.2

1.3

28.69

36.67

u/l

0.71

132

987

Wide developmental disorders

111

2.08

2.70

1.3

1.2

60.92

33.59

u/l

0.21

103

Other infective otitis externa

421

1.53

2.70

1.8

1.2

18.35

34.93

u/l

1.77

360

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

192

1495

1.27

2.70

1.2

27.03

33.76

u/l

0.41

168

1322

Malignant neoplasm of pancreas, including Hilmo

549

0.56

2.69

1.1

1.2

18.61

18.49

u/l

0.01

468

Maternal care for known or suspected malpresentation of fetus

511

0.61

2.69

1.3

1.2

39.27

27.11

u/l

0.27

453

Abnormal serum enzyme levels

349

2827

1.20

2.69

1.6

1.3

40.71

34.95

u/l

0.27

312

2436

Diabetic retinopathy

493

2632

1.17

2.68

1.2

38.58

28.47

u/l

0.85

427

2295

Autoimmune hepatitis

2.85

2.67

1.2

1.3

17.39

16.61

u/l

0.05

Asthma and allergy

593

1.44

2.67

1.3

1.2

16.12

18.98

u/l

0.36

517

Chronic diseases of tonsils and adenoids

726

4046

1.13

2.65

1.3

31.08

30.34

u/l

0.04

642

3535

Other problems related to primary support group, including family circumstances

506

1.47

2.63

1.2

1.3

37.88

25.90

u/l

0.36

446

Allergic urticaria

464

1.50

2.63

1.3

1.2

44.59

35.72

u/l

0.11

396

Other disorders starting during childhood or adolescence

139

1.93

2.62

1.4

1.5

11.58

33.47

u/l

0.82

129

Other and unspecified hereditary haemolytic anaemias

7.81

2.61

8.8

1.1

53.44

8.34

u/l

—

Seronegative rheumatoid arthritis

104

756

1.38

2.60

1.1

1.3

121.39

35.63

u/l

1.31

655

Persons with potential health hazards related to communicable diseases

282

2308

1.21

2.59

1.4

1.3

34.00

32.89

u/l

0.06

260

2026

Allergic conjunctivitis

480

3991

1.16

2.58

1.3

1.2

24.61

33.19

u/l

1.60

403

3501

Chronic viral hepatitis

299

1.62

2.57

1.3

58.56

30.90

u/l

0.49

257

Mental and behavioural disorders due to multiple drug use and use of multiple drugs and use of other psychoactive substances

410

1.52

2.56

1.1

1.3

53.16

29.80

u/l

0.26

359

Dementia

385

3089

0.85

2.53

1.3

33.20

41.80

u/l

0.69

331

2648

Carcinoma in situ of skin

694

1.39

2.51

1.2

26.05

38.86

u/l

1.08

597

Use of galantamine

661

0.62

2.51

1.2

24.14

41.32

u/l

1.81

569

239

1819

1.23

2.50

1.4

1.3

42.03

38.90

u/l

0.18

187

1570

Fibroblastic disorders

238

1942

1.23

2.50

1.4

1.3

48.21

33.67

u/l

0.43

208

1662

Follicular cysts of skin and subcutaneous tissue

182

1442

1.27

2.49

1.2

1.3

39.52

32.39

u/l

0.27

160

1251

Ménière disease

695

1.39

2.49

1.2

1.3

34.41

31.27

u/l

0.09

595

Deviated nasal septum

342

2886

1.19

2.49

1.3

29.08

28.07

u/l

0.08

302

2507

Malignant neoplasm of colon

129

977

1.33

2.49

1.2

31.13

20.51

u/l

1.37

112

828

Pyoderma gangrenosum

2.73

2.48

1.2

44.55

17.74

u/l

0.98

Conjunctivitis (acute, non atopic), including avohilmo

1040

5686

1.11

2.47

1.3

31.07

33.11

u/l

0.21

891

5002

Synovial cyst of popliteal space [Baker]

504

1.46

2.46

1.2

23.15

37.59

u/l

1.28

428

Excessive vomiting in pregnancy

318

1.58

2.46

1.1

1.2

11.73

18.27

u/l

1.92

269

Colorectal cancer

207

1599

1.25

2.45

1.2

56.34

20.33

u/l

1.29

177

1359

Acute pharyngitis

122

910

1.33

2.44

1.3

50.16

26.54

u/l

1.09

108

802

Cerebral palsy and other paralytic syndromes

106

783

1.36

2.43

1.3

1.2

39.66

40.22

u/l

0.01

675

Pathological/recurrent dislocation and subluxation of joint, not elsewhere classified

456

1.48

2.43

1.3

32.97

31.30

u/l

0.04

394

Female infertility, associated with anovulation

226

1.69

2.43

1.5

1.2

8.90

28.40

u/l

1.58

200

Iridocyclitis

218

1770

1.24

2.42

1.6

1.2

48.79

30.92

u/l

1.11

192

1523

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

456

3781

1.16

2.42

1.3

1.2

24.64

32.89

u/l

1.43

385

3316

Chondropathies

136

1043

1.31

2.41

1.1

1.3

15.82

35.44

u/l

4.08

107

908

Benign neoplasm: Small intestine

289

1.61

2.41

1.1

1.3

45.89

40.98

u/l

0.10

248

Caries of enamel

954

5638

1.11

2.41

1.3

33.58

32.11

u/l

0.10

835

4950

Injury of unspecified body region

548

1.43

2.41

1.2

1.3

18.19

39.71

u/l

2.35

465

Bell's palsy

117

879

1.34

2.41

1.4

1.3

33.83

39.88

u/l

0.25

107

758

Spirochaetal infections, other/unspecified, including avohilmo

224

2738

0.82

2.41

1.5

1.3

33.56

30.73

u/l

0.16

193

2366

Familial hypercholesterolemia, with ischemic heart disease

101

743

1.37

2.39

1.2

1.3

28.69

44.91

u/l

1.17

638

Other abnormalities of plasma proteins

104

2.06

2.39

1.0

1.2

48.44

48.75

u/l

0.00

Coeliac disease

106

786

1.36

2.38

1.2

27.03

31.99

u/l

0.29

682

Injuries to unspecified part of trunk, limb or body region

103

761

1.36

2.37

1.2

18.13

44.59

u/l

3.80

656

Other Crohn's disease

418

1.49

2.37

1.2

22.53

33.04

u/l

0.69

358

Supervision of normal pregnancy

548

0.69

2.36

1.2

25.57

37.21

u/l

0.37

488

Malignant neoplasm of corpus uteri

402

1.50

2.36

1.2

69.99

22.73

u/l

0.44

343

Behavioural syndromes associated with physiological disturbances and physical factors

928

5674

1.11

2.35

1.2

1.3

27.49

33.11

u/l

0.57

804

4959

Acute and transient psychotic disorders

728

1.37

2.35

1.2

17.41

35.75

u/l

1.94

626

Convulsions, not elsewhere classified

202

1612

1.24

2.34

1.3

31.42

26.57

u/l

0.34

174

1384

Other noninflammatory disorders of uterus, except cervix

169

887

1.28

2.34

1.2

34.58

34.14

u/l

0.01

146

758

Gonarthrosis, primary, with knee surgery

624

4300

1.13

2.34

1.4

1.3

37.23

34.66

u/l

0.16

542

3717

Intestinal stricture

322

2724

1.19

2.34

1.2

1.3

34.87

34.77

u/l

0.00

281

2344

Hypothyroidism due to medicaments and other exogenous substances

2.35

2.34

1.2

12.23

16.29

u/l

0.60

Other specified/unspecified systemic involvement of connective tissue

347

1.54

2.33

1.3

1.2

63.73

22.31

u/l

0.67

301

Recurrent dislocation and subluxation of joint

379

1.51

2.33

1.3

34.20

35.33

u/l

0.02

326

Fracture of femur

291

2198

1.20

2.32

1.5

1.3

33.49

37.98

u/l

0.38

261

1872

Trigger finger

135

1041

1.30

2.32

1.1

1.2

27.25

36.75

u/l

0.42

128

897

Carbimazole or st.post thyroidectomy, condition for graves disease

176

1403

1.26

2.31

1.3

1.2

36.59

30.39

u/l

0.26

156

1219

Crohn disease (strict definition, require KELA, min 2 HDR)

380

1.51

2.31

1.2

1.3

60.31

31.41

u/l

0.35

327

Plantar fascial fibromatosis

638

1.39

2.29

1.3

20.18

35.36

u/l

1.37

546

Superficial injury of hip and thigh

151

1184

1.28

2.28

1.3

58.57

40.37

u/l

0.36

134

1015

Special screening examination for infectious and parasitic diseases

164

942

1.27

2.28

1.3

29.25

22.05

u/l

0.24

137

821

Follow-up examination after treatment for malignant neoplasms

630

1.39

2.28

1.2

40.42

31.88

u/l

0.29

520

Postmenopausal bleeding

211

891

1.24

2.27

1.3

1.2

37.51

34.02

u/l

0.09

189

762

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

298

2512

1.19

2.27

1.4

1.3

26.63

29.14

u/l

0.23

277

2183

Carrier of infectious disease

142

1.85

2.25

1.2

18.40

18.65

u/l

0.01

122

Malignant neoplasm of colon, including Hilmo

156

1227

1.27

2.23

1.2

34.42

20.21

u/l

1.65

139

1043

Other/unspecified enthesopathies, not elsewhere classified

574

1.40

2.22

1.2

1.3

89.52

42.44

u/l

0.50

492

Follow-up care involving plastic surgery

233

1.65

2.21

1.4

1.2

33.61

19.79

u/l

0.71

200

Thyrotoxicosis

219

1799

1.22

2.20

1.3

1.2

40.13

32.70

u/l

0.20

201

1563

Lyme disease, including avohilmo

224

2710

0.82

2.20

1.5

1.3

33.56

30.86

u/l

0.15

193

2343

Lyme disease

224

2710

0.82

2.20

1.5

1.3

33.56

30.86

u/l

0.15

193

2343

Dermatophytosis, including avohilmo

655

5731

1.12

2.20

1.3

29.44

32.38

u/l

0.29

557

5031

Crohn disease (strict definition, require KELA)

385

1.49

2.18

1.2

1.3

60.31

31.06

u/l

0.35

332

Nonorganic sleeping disorders, excluding more controls

164

1308

1.26

2.17

1.3

1.2

19.22

30.40

u/l

1.77

147

1138

Strabismus

232

1915

1.21

2.16

1.3

30.31

31.46

u/l

0.04

214

1670

Spondylolisthesis/Spondylolysis

172

1381

1.25

2.16

1.5

1.2

28.97

29.84

u/l

0.05

156

1180

Lichen simplex chronicus and prurigo

428

1.46

2.14

1.4

1.2

20.41

36.60

u/l

1.43

366

Disorders of muscles

715

1.35

2.13

1.2

1.3

26.51

41.44

u/l

0.78

619

Personal history of other diseases and conditions

500

1.42

2.13

1.3

29.37

23.16

u/l

0.38

429

Sudden idiopathic hearing loss

101

759

1.34

2.12

1.3

1.2

35.27

38.97

u/l

0.15

661

Dementia in Alzheimer disease

138

1464

0.78

2.11

1.3

25.06

39.75

u/l

2.67

108

1238

Amputation of thigh

213

1.66

2.11

1.1

1.2

31.16

42.39

u/l

0.45

186

Ulcerative ileocolitis

252

1.60

2.11

1.3

24.18

36.72

u/l

0.52

215

Renal cell carcinoma of kidney

175

1.73

2.10

2.1

1.1

47.81

21.39

u/l

0.45

152

Chronic pancreatitis

131

1022

1.29

2.10

1.2

1.3

18.68

36.14

u/l

2.91

117

888

Cervicobrachial syndrome

193

1574

1.23

2.10

1.2

27.46

30.00

u/l

0.15

173

1350

Fentanyl

733

1.34

2.09

1.4

1.2

39.48

36.18

u/l

0.13

619

Later onset COPD

322

2209

1.17

2.07

1.2

1.3

30.93

40.20

u/l

1.20

278

1906

Other spirochaetal diseases, including avohilmo

231

2765

0.83

2.05

1.5

1.3

32.83

30.57

u/l

0.13

200

2390

Primary coxarthrosis, bilateral

301

2567

1.18

2.04

1.4

1.3

45.85

34.01

u/l

0.46

263

2198

Other acute skin changes due to ultraviolet radiation

223

1.63

2.04

1.1

1.2

14.87

36.27

u/l

1.93

195

Ulcer of oesophagus

542

1.39

2.03

1.6

1.3

40.48

38.22

u/l

0.07

466

Impingement syndrome of shoulder

227

1889

1.21

2.03

1.3

22.61

33.87

u/l

2.33

203

1635

Other and unspecified injuries of lower leg

466

1.42

2.03

1.2

1.3

13.24

32.79

u/l

2.36

406

Other congenital malformations

449

1.43

2.03

1.2

53.24

34.81

u/l

0.23

388

Sicca syndrome [Sjögren]

542

1.39

2.03

1.2

20.87

24.96

u/l

0.56

472

Autoimmune hepatitis, wide definition

271

1.56

2.01

1.3

1.2

23.17

35.66

u/l

0.66

231

Other misadventures during surgical and medical care

178

1.71

2.01

1.2

24.77

36.21

u/l

0.39

154

Symptoms and signs involving speech and voice

317

2719

1.17

2.00

1.2

1.3

40.78

32.60

u/l

0.50

280

2346

Fracture of shoulder and upper arm

352

3039

1.16

2.00

1.3

43.92

32.59

u/l

0.62

306

2608

Other symptoms and signs involving the digestive system and abdomen

149

1189

1.26

2.00

1.2

19.02

35.79

u/l

2.81

124

1014

Crohn's disease patients in KELA-register (KELA code 209, or 208 with ICD K50)

410

1.45

1.99

1.3

58.46

35.58

u/l

0.27

354

Other spirochaetal diseases

230

2741

0.84

1.96

1.5

1.3

32.95

30.65

u/l

0.13

199

2369

Crohn disease (strict definition, all UC cases excluded)

321

1.51

1.96

1.2

66.84

33.52

u/l

0.33

277

Striking against or struck by other objects

312

2673

1.17

1.96

1.4

1.3

39.16

28.29

u/l

0.54

274

2333

Lichen sclerosus et atrophicus

717

1.33

1.96

1.5

1.2

27.85

26.41

u/l

0.06

617

Other maternal disorders predominantly related to pregnancy

357

1927

1.16

1.95

1.2

23.25

29.62

u/l

0.77

315

1684

Acromegaly and pituitary gigantism

2.79

1.95

1.3

1.2

11.96

17.69

u/l

—

Rosacea

112

866

1.30

1.94

1.3

1.2

23.66

35.91

u/l

1.23

101

746

Acute lymphadenitis

338

1.49

1.94

1.2

61.87

38.31

u/l

0.32

290

Scoliosis

462

1.41

1.94

1.3

1.2

48.06

29.34

u/l

0.76

398

Other symptoms and signs involving the urinary system

112

867

1.30

1.94

1.5

1.3

49.36

39.26

u/l

0.26

103

753

Delivery

225

1422

0.83

1.94

1.2

28.01

37.58

u/l

0.84

188

1231

Isolated proteinuria with specified morphological lesion

2.09

1.93

1.2

19.61

20.04

u/l

0.03

Other disorders of pigmentation

282

1.54

1.93

1.1

1.3

47.70

31.95

u/l

0.37

241

Other specified disorders of kidney and ureter

227

1.60

1.92

1.3

28.78

34.31

u/l

0.14

199

Malignant neoplasm of mesothelium and soft tissue, including Hilmo

397

1.44

1.91

1.2

58.37

18.36

u/l

0.78

339

Radial styloid tenosynovitis [de Quervain]

307

1.51

1.90

1.2

1.3

13.57

33.62

u/l

1.83

273

Use of entacapone

0.00

1.90

0.0

1.2

—

33.29

—

Speech and linguistic disorders

404

1.43

1.90

1.2

1.3

24.54

27.71

u/l

0.16

356

Other and unspecified urticaria

158

1279

1.24

1.88

1.3

28.41

31.47

u/l

0.08

139

1102

Other endocrine disorders

233

1.57

1.88

1.2

1.4

42.28

40.23

u/l

0.04

204

Benign neoplasm: Skin of trunk

284

1.53

1.88

1.2

1.3

15.78

39.57

u/l

2.01

246

Atrophic disorders of skin

127

1003

1.27

1.88

1.4

1.2

24.45

29.06

u/l

0.27

108

866

Special screening examination for neoplasms

407

1.43

1.87

1.2

1.4

50.17

24.94

u/l

0.92

340

Hallux valgus (acquired)

282

1718

1.18

1.87

1.2

1.3

33.65

33.97

u/l

0.01

244

1477

Excessive earwax

668

5467

1.11

1.87

1.3

37.16

33.18

u/l

0.21

575

4770

Olecranon bursitis

517

1.38

1.87

1.2

1.3

25.14

46.08

u/l

1.52

448

Artificial joint re-operation

534

1.38

1.87

1.2

28.97

35.56

u/l

0.27

458

Routine general health check-up of defined subpopulation

2.10

1.87

1.2

11.05

14.43

u/l

0.47

Keratitis

337

2923

1.16

1.86

1.3

34.39

30.11

u/l

0.22

303

2528

Other disorders of bladder

127

1005

1.27

1.86

1.2

1.3

26.34

36.60

u/l

0.92

109

871

Malignant melanoma of skin

100

767

1.31

1.86

1.2

88.32

18.75

u/l

1.45

654

Persistent delusional disorders

509

1.38

1.85

1.2

18.13

37.61

u/l

1.52

435

Excessive attrition of teeth

551

4880

1.12

1.85

1.3

24.78

31.00

u/l

0.92

473

4287

Pain associated with micturition

112

873

1.29

1.85

1.4

1.3

24.00

39.94

u/l

1.26

759

Ulcerative colitis, NAS

124

979

1.27

1.85

1.2

1.3

21.71

35.43

u/l

1.88

113

852

303

0.53

1.84

1.3

1.2

10.08

19.03

u/l

1.15

263

Sleep disorders

879

5536

1.09

1.83

1.2

1.3

27.91

33.11

u/l

0.48

762

4836

Event of undetermined intent

418

1.42

1.82

1.1

1.3

26.77

37.36

u/l

0.47

360

Insomnia

854

5431

1.09

1.81

1.3

28.19

32.86

u/l

0.40

739

4741

Autism

1.97

1.80

1.4

1.2

78.14

36.93

u/l

0.24

Noninflammatory disorders of female genital tract

253

1071

1.19

1.80

1.3

1.2

19.93

35.79

u/l

2.67

214

925

Chronic conjunctivitis

184

1.65

1.79

1.2

57.30

19.82

u/l

0.72

158

Injury of muscle and tendon at shoulder and upper arm level

385

3383

1.14

1.79

1.3

24.90

31.16

u/l

1.01

338

2942

Complications following infusion, transfusion and therapeutic injection

102

1.89

1.78

1.4

1.2

40.76

19.23

u/l

0.36

Other keratitis

101

782

1.30

1.77

1.3

1.2

30.52

38.24

u/l

0.20

677

Hypertrophy of breast in women and men

143

1155

1.24

1.76

1.2

24.82

32.05

u/l

0.53

120

1007

Other disorders of optic [2nd] nerve and visual pathways

421

1.41

1.76

1.2

1.3

25.28

34.61

u/l

0.52

365

Superficial injury of ankle and foot

765

1.30

1.76

1.2

1.3

42.70

34.52

u/l

0.23

665

Follicular adenocarcinoma of thyroid gland, including Hilmo

2.26

1.75

1.2

9.58

17.71

u/l

1.11

Malignant neoplasm of corpus uteri, including Hilmo

455

1.39

1.75

1.2

66.60

21.64

u/l

0.44

387

Dislocation, sprain and strain of joints and ligaments of knee

554

4499

1.11

1.74

1.4

1.3

18.09

31.24

u/l

5.65

485

3953

Papillary adenocarcinoma of thyroid gland

266

1.51

1.71

1.3

1.2

18.01

17.03

u/l

0.09

227

Brain meningioma

258

1.52

1.71

1.1

1.2

32.07

17.34

u/l

0.67

222

Autism spe

1.92

1.70

1.4

1.2

78.14

36.20

u/l

0.25

Voice disturbances

246

2101

1.17

1.70

1.3

39.77

32.02

u/l

0.49

222

1820

Childhood asthma (age<16), excluding more controls

375

1.38

1.70

1.1

1.2

58.38

17.14

u/l

0.40

329

Erosion of teeth , including avohilmo

219

1853

1.18

1.69

1.4

1.3

46.99

29.10

u/l

0.84

196

1610

Malignant neoplasm of head and neck, including Hilmo

630

1.32

1.69

1.6

1.2

29.79

18.36

u/l

1.27

534

Unspecified urinary incontinence

588

1.33

1.67

1.2

28.61

34.61

u/l

0.38

508

Single spontaneous delivery

228

1420

0.85

1.67

1.2

27.78

37.61

u/l

0.88

191

1230

Infections with a predominantly sexual mode of transmission

210

1769

1.19

1.66

1.3

1.2

19.22

28.88

u/l

1.79

178

1550

Monoarthritis, not elsewhere classified

252

1.52

1.66

1.2

1.3

18.06

29.64

u/l

1.10

215

Schizophrenia or delusion

270

2328

1.16

1.66

1.2

1.3

25.23

31.17

u/l

0.44

230

2040

Disorders of optic nerve and visual pathways

598

1.33

1.65

1.2

28.55

37.72

u/l

0.51

516

Social phobias

401

1.40

1.64

1.3

1.2

41.90

25.90

u/l

0.28

350

Radiculopathy

152

1248

1.22

1.63

1.3

1.2

26.07

32.89

u/l

0.39

135

1057

Fracture of skull and facial bones

208

1759

1.19

1.63

1.2

1.3

37.07

30.62

u/l

0.33

181

1525

Hyperfunction of pituitary gland

253

1.51

1.63

1.1

1.2

18.51

40.04

u/l

1.20

219

Psoriasis vulgaris

180

1504

1.20

1.62

1.3

23.87

32.69

u/l

0.80

159

1313

Anterior Iridocyclitis

185

1551

1.20

1.61

1.5

1.3

51.64

33.92

u/l

0.86

160

1348

therapeutic use

222

1.55

1.61

1.2

34.12

36.22

u/l

0.03

196

Pollen allergy

122

966

1.25

1.60

1.4

1.3

19.38

28.79

u/l

0.92

106

842

Inflammatory diseases of prostate (prostatitis)

139

1134

1.23

1.60

1.3

17.43

35.41

u/l

4.75

117

977

Barrett oesophagus

404

1.40

1.60

1.8

1.3

37.03

39.46

u/l

0.06

343

Other congenital malformations, including avohilmo

688

1.30

1.60

1.2

1.3

48.28

32.77

u/l

0.27

597

IBD patients in KELA-register

197

1662

1.19

1.59

1.2

1.3

36.69

31.78

u/l

0.16

178

1448

Dental pulpitis, including avohilmo

861

5075

1.09

1.59

1.3

25.36

30.14

u/l

0.65

759

4441

Benign paroxysmal vertigo

278

2412

1.16

1.59

1.3

1.2

27.54

35.15

u/l

0.77

251

2075

Childhood asthma (age<16)

380

1.36

1.59

1.1

1.2

58.38

17.20

u/l

0.40

335

Nonsuppurative otitis media, including avohilmo

235

1737

1.17

1.59

1.2

1.3

41.20

33.74

u/l

0.21

213

1513

Malignant neoplasm of digestive organs, including Hilmo

353

2282

1.14

1.59

1.2

51.39

20.07

u/l

2.27

313

1957

Atopic conjunctivitis

255

1.50

1.58

1.2

1.3

34.86

27.20

u/l

0.22

220

Congenital malformations of the circulatory system

119

928

1.25

1.58

1.2

1.3

37.08

33.97

u/l

0.13

102

812

Persons encountering health services in circumstances related to reproduction

412

3102

0.89

1.57

1.3

30.37

28.71

u/l

0.10

366

2730

Spontaneous abortion

225

1764

0.85

1.57

1.2

44.49

29.52

u/l

0.46

193

1549

Oral leukoplakia and other epithelial disorders of tongue and oral cavity , including avohilmo

691

1.29

1.57

1.7

1.2

33.17

33.99

u/l

0.03

596

Vascular dementia (mixed)

145

1.67

1.55

1.5

1.2

60.23

41.09

u/l

0.24

130

Seropositive rheumatoid arthritis

209

1767

1.18

1.55

1.3

64.69

34.32

u/l

0.82

190

1504

Inflammatory disease of uterus

630

1.31

1.55

1.4

1.2

17.65

19.81

u/l

0.21

548

Hepatocellular carcinoma, including Hilmo

184

1.59

1.55

1.4

1.2

46.23

21.43

u/l

0.79

156

Erectile dysfunction

737

1.28

1.55

2.1

1.3

32.39

45.35

u/l

0.76

644

Lateral epicondylitis

112

896

1.25

1.55

1.3

11.56

32.54

u/l

4.73

106

780

Glaucoma

595

4591

1.10

1.54

1.3

25.01

37.36

u/l

4.59

502

3987

Superficial frostbite

0.00

1.54

0.0

1.4

—

15.39

—

Labour and delivery complicated by fetal stress [distress]

573

0.75

1.54

1.2

36.38

23.82

u/l

0.25

511

Conductive hearing loss, unspecified

562

1.32

1.53

1.7

1.3

85.76

38.45

u/l

0.77

492

Lung diseases due to external agents

141

1159

1.22

1.52

1.4

1.3

47.18

40.83

u/l

0.18

120

989

Assault

110

880

1.25

1.52

1.3

1.2

29.25

33.75

u/l

0.17

766

Superficial injury of wrist and hand

172

1441

1.20

1.52

1.2

1.3

16.63

31.63

u/l

3.03

146

1259

Ulcerative enterocolitis

193

1.57

1.52

1.2

1.3

31.08

35.43

u/l

0.15

159

Acute and subacute iridocyclitis

173

1451

1.20

1.52

1.5

1.2

53.65

32.96

u/l

0.99

149

1254

Schizophrenia, schizotypal and delusional disorders

270

2348

1.15

1.51

1.2

1.3

25.11

31.19

u/l

0.46

230

2057

Other disorders of eye and adnexa

118

953

1.24

1.51

1.2

1.3

43.13

33.17

u/l

0.21

104

826

Brain meningioma, including Hilmo

267

1.47

1.49

1.1

1.2

32.07

17.32

u/l

0.67

230

Other condition

130

1063

1.23

1.49

1.2

1.3

31.94

36.33

u/l

0.22

115

925

Drug-induced neutropenia

496

1.34

1.48

1.2

1.3

120.22

37.36

u/l

2.48

427

Nontoxic goitre/thyroid nodule

251

2175

1.16

1.48

1.3

1.2

29.57

36.55

u/l

0.63

217

1864

Pedal cyclist injured in transport accident

142

1713

0.83

1.48

1.3

23.38

32.82

u/l

1.01

125

1485

Secondary parkinsonism, excluding more controls

171

1.59

1.47

1.1

1.2

20.76

34.90

u/l

0.63

148

Abnormal findings on diagnostic imaging of central nervous system

310

1.43

1.46

1.2

40.96

38.79

u/l

0.05

264

Tinnitus

220

1891

1.17

1.45

1.3

32.92

31.11

u/l

0.08

192

1642

Otitis media, unspecified

505

1.32

1.45

1.3

34.06

30.94

u/l

0.06

439

Postprocedural musculoskeletal disorders, not elsewhere classified

559

1.31

1.45

1.8

1.3

39.03

36.38

u/l

0.09

482

Orthopaedic devices associated with adverse incidents

125

1.70

1.45

1.2

47.18

26.00

u/l

0.27

105

conjunctival haemorrhage

603

1.30

1.45

1.2

1.3

41.03

32.64

u/l

0.27

522

Other papulosquamous disorders

2.00

1.45

1.4

1.2

63.88

17.84

u/l

0.43

Endometriosis of pelvic peritoneum

675

1.27

1.44

1.3

1.2

16.94

28.43

u/l

1.29

587

Impaction of intestines

2.35

1.44

1.2

1.3

10.66

31.02

u/l

—

Vitamin deficiency

294

1.44

1.5

1.3

70.76

33.71

u/l

0.57

252

Vitamin deficiency, wide

294

1.44

1.5

1.3

70.76

33.71

u/l

0.57

252

Suppurative and necrotic conditions of lower respiratory tract

456

1.35

1.43

1.9

1.3

39.37

45.11

u/l

0.16

395

Vaginitis/vulvovaginitis/vulvitis/abscess of vulva

108

870

1.24

1.42

1.2

26.31

22.47

u/l

0.23

753

Other otitis externa (chronic)

465

1.34

1.42

1.2

18.54

32.98

u/l

1.44

395

Hemiplegia

312

1.42

1.41

1.2

23.53

34.81

u/l

0.75

270

Allergic rhinitis

224

1908

1.16

1.41

1.3

1.2

22.76

30.43

u/l

0.98

201

1670

Other encephalitis

181

1.56

1.41

1.2

1.3

140.92

35.67

u/l

0.63

159

Other and unspecified vascular occlusions

756

1.26

1.41

1.4

1.3

30.88

45.39

u/l

0.94

658

Visual field defects

632

1.29

1.41

1.1

1.2

36.95

36.73

u/l

0.00

546

Sacrococcygeal disorders, not elsewhere classified

181

1.56

1.40

1.2

1.3

13.62

26.79

u/l

1.17

156

Superficial injury of thorax

145

1207

1.21

1.40

1.5

1.3

50.41

36.70

u/l

0.62

131

1046

Eating disorder

295

1.42

1.40

1.2

1.3

31.08

24.93

u/l

0.12

250

Other and/or unspecified nontoxic goitre

484

1.33

1.39

1.3

1.2

26.48

34.09

u/l

0.36

413

Respiratory conditions due to other external agents

150

1.62

1.39

1.4

1.2

70.25

31.25

u/l

0.52

129

Other and unspecified mononeuropathies of upper limb

206

1.52

1.38

1.4

1.2

18.03

31.89

u/l

1.01

171

Other necrotizing vasculopathies

546

1.31

1.38

1.2

1.3

39.92

36.24

u/l

0.12

466

Use of levodopa decarboxylase inhibitor

102

1260

0.81

1.37

1.1

1.3

24.24

39.97

u/l

1.21

1088

Other predominantly sexually transmitted diseases, not elsewhere classified

109

884

1.24

1.37

1.4

1.3

20.64

23.28

u/l

0.22

775

Inflammatory bowel disease, strict (require KELA)

197

1690

1.17

1.36

1.2

1.3

36.69

32.15

u/l

0.15

178

1474

Varicose veins of other sites

487

1.32

1.35

1.2

1.3

78.93

45.22

u/l

0.25

412

Diabetes insipidus

2.07

1.34

1.2

11.48

12.89

u/l

0.19

Pedal cyclist injured in collision with pedestrian or animal

0.00

1.34

0.0

1.2

—

14.94

—

613

4892

1.09

1.33

1.2

1.3

29.67

30.94

u/l

0.13

525

4286

Atopic dermatitis

398

3521

0.90

1.33

1.3

37.93

27.34

u/l

0.44

350

3085

Post-traumatic wound infection, not elsewhere classified

192

1.52

1.33

1.3

1.2

23.48

39.04

u/l

0.79

167

Pyothorax

342

1.38

1.33

1.9

1.3

48.03

41.58

u/l

0.14

298

Neovascular glaucoma

283

1.42

1.32

1.3

21.39

40.48

u/l

1.31

244

Follicular lymphoma, hilmo

300

1.41

1.32

1.3

1.2

72.33

37.47

u/l

0.78

256

Injuries to the ankle and foot

656

5157

1.09

1.32

1.3

34.57

30.73

u/l

0.31

577

4515

Diseases of the myoneural junction and muscle

121

998

1.22

1.31

1.2

1.3

22.21

42.07

u/l

3.13

862

Hypoplasia of dental enamel , including avohilmo

1.75

1.31

2.1

1.6

16.93

15.27

u/l

0.07

Other and unspecified injuries of head

551

1.29

1.30

1.2

17.33

37.49

u/l

2.45

466

Dementia, including avohilmo

432

3256

0.90

1.30

1.2

1.3

32.53

41.49

u/l

0.84

373

2793

Hyphaema and other vascular disorders of iris and ciliary body

161

1.57

1.30

1.3

1.2

39.30

34.84

u/l

0.10

141

Other disorders of patella

129

1073

1.21

1.28

1.4

1.3

17.15

32.71

u/l

2.81

109

934

Infectious mononucleosis, including avohilmo

378

1.35

1.28

1.1

1.3

20.94

25.19

u/l

0.21

326

Infectious mononucleosis

378

1.35

1.28

1.1

1.3

20.94

25.19

u/l

0.21

326

Family history of other conditions

1.95

1.28

1.1

1.3

13.89

19.19

u/l

0.54

Dislocation, sprain and strain of joints and ligaments at neck level

118

974

1.21

1.27

1.3

16.16

33.87

u/l

3.37

104

849

Reactive arthropathies

562

1.29

1.27

1.8

1.3

25.36

41.02

u/l

1.12

488

Premature rupture of membranes

638

0.78

1.26

1.1

1.2

23.71

27.99

u/l

0.13

568

Male infertility

294

1.40

1.26

1.4

1.3

18.50

29.14

u/l

0.43

257

Other noninflammatory disorders of vulva and perineum

492

1.30

1.26

1.2

22.55

29.34

u/l

0.34

424

Idiopathic pulmonary fibrosis

643

1.27

1.26

1.1

1.3

48.45

41.45

u/l

0.10

542

Acute alcohol intoxication

193

2231

0.86

1.25

1.2

1.3

31.40

30.43

u/l

0.05

154

1947

False labour

102

777

0.81

1.25

1.2

1.3

19.77

31.29

u/l

0.61

694

Other and unspecified papulosquamous disorders

2.26

1.25

1.3

1.2

97.82

22.95

u/l

—

Ptosis of eyelid

110

904

1.22

1.25

1.2

1.3

25.44

38.19

u/l

1.19

782

Other deformity of hallux (acquired)

2.03

1.24

1.0

1.3

37.09

17.29

u/l

—

Reactive arthropathies, FINNGEN

450

1.32

1.24

1.9

1.3

23.31

36.43

u/l

0.73

388

Malignant neoplasm, without specification of site, including Hilmo

253

1.43

1.24

1.2

58.21

21.12

u/l

0.85

221

Malignant neoplasm of breast, ER-negative, including Hilmo

127

990

1.20

1.23

1.2

30.15

20.74

u/l

1.05

108

859

Carcinoma in situ of skin of upper limb, including shoulder

204

1.49

1.23

1.2

92.64

45.33

u/l

0.29

174

Benign neoplasm of brain and other parts of central nervous system

442

1.32

1.23

1.4

1.3

32.21

38.08

u/l

0.24

378

Malignant neoplasm of parotid gland, including Hilmo

1.99

1.23

1.2

1.1

26.63

13.82

u/l

0.99

Nonsuppurative otitis media

160

1181

1.18

1.22

1.2

1.3

52.72

37.14

u/l

0.33

145

1032

Perforation of tympanic membrane

700

1.25

1.21

1.2

21.68

37.67

u/l

1.02

600

Supplementary factors related to causes of morbidity and mortality classified elsewhere

287

2553

1.13

1.20

1.3

28.62

31.14

u/l

0.22

241

2230

Colectomy operation

165

1413

1.17

1.20

1.2

1.3

27.01

38.38

u/l

1.63

150

1223

Other necrotizing vasculopathies (FG)

409

1.33

1.20

1.1

1.3

43.23

37.65

u/l

0.15

355

Puerperal sepsis

656

1.25

1.20

1.3

1.2

34.24

23.30

u/l

0.36

568

Other and unspecified acute skin changes due to ultraviolet radiation

173

1.52

1.19

1.0

1.2

15.27

37.42

u/l

1.43

149

Maternal care for cervical incompetence

181

1.50

1.18

1.3

1.2

17.89

20.62

u/l

0.17

150

Morphin

157

1.54

1.18

1.1

1.2

40.89

27.89

u/l

0.34

139

Otitis externa, unspecified

784

1.23

1.17

1.3

1.2

15.79

37.60

u/l

3.29

676

Ocular pain

525

1.28

1.17

1.2

58.95

31.70

u/l

0.35

448

Perforation of oesophagus

2.10

1.17

1.1

1.2

21.14

30.43

u/l

—

Other and unspecified disorders of pigmentation

2.08

1.16

1.1

1.2

35.83

14.42

u/l

—

Deep bite

531

1.26

1.15

1.3

15.07

27.57

u/l

1.60

460

Melanocytic naevi, other sites/unspecified

553

1.27

1.15

1.2

1.3

43.49

38.44

u/l

0.12

480

Benign neoplasm: Connective and other soft tissue of trunk, unspecified

0.00

1.15

0.0

1.2

—

24.07

—

Hereditary corneal dystrophies

241

1.42

1.14

1.2

100.38

30.21

u/l

0.50

208

Salpingitis and oophoritis

119

996

1.20

1.14

1.4

1.2

46.19

24.40

u/l

0.60

105

869

Sequelae of injuries of upper limb

706

1.24

1.14

1.7

1.2

24.95

39.35

u/l

1.08

610

≡ Risteys

R14

FinnGen R13 + FinRegistry

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Erythropoietin (EPO) [Units/volume] in Serum or Plasma

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS